Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	CDK9 SMG1 CRIM1 MARK1 INSR CDKL3 MAST2 TRRAP MELK AURKC GRK2 GRK3 ETNK1 FGFR3 UAP1L1 HJV BMP2K LMTK2 PARP14 POLR3A ITPKC MTOR BRD4 PRKG1 TNKS2	1.05e-05	938	203	25	GO:0016772
GeneOntologyMolecularFunction	kinase activity	CDK9 SMG1 CRIM1 MARK1 INSR CDKL3 MAST2 TRRAP MELK AURKC GRK2 GRK3 ETNK1 FGFR3 HJV BMP2K LMTK2 ITPKC MTOR BRD4 PRKG1	3.60e-05	764	203	21	GO:0016301
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	CDK9 SMG1 CRIM1 MARK1 INSR CDKL3 MAST2 MELK AURKC GRK2 GRK3 ETNK1 FGFR3 HJV BMP2K LMTK2 ITPKC MTOR BRD4 PRKG1	3.89e-05	709	203	20	GO:0016773
GeneOntologyMolecularFunction	microfilament motor activity	MYH9 MYH10 MYO1A MYO19 MYO15A	3.95e-05	38	203	5	GO:0000146
GeneOntologyMolecularFunction	protein kinase activity	CDK9 SMG1 CRIM1 MARK1 INSR CDKL3 MAST2 MELK AURKC GRK2 GRK3 FGFR3 HJV BMP2K LMTK2 MTOR BRD4 PRKG1	4.38e-05	600	203	18	GO:0004672
GeneOntologyMolecularFunction	cytoskeletal protein binding	MYH9 MYH10 PDE4B MYO1A MARK1 MAST2 DDX3X HNRNPK ADD2 DLC1 SYNE2 DIAPH1 CAMSAP1 TRIM36 BICD2 VIL1 APPBP2 SYNE1 MYO19 LMTK2 GRIA1 ADNP SETD2 MYO15A EPB41L1 EPB41L2	5.32e-05	1099	203	26	GO:0008092
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	CDK9 SMG1 MARK1 CDKL3 MAST2 MELK AURKC GRK2 GRK3 HJV BMP2K LMTK2 MTOR BRD4 PRKG1	5.46e-05	446	203	15	GO:0004674
GeneOntologyMolecularFunction	calmodulin binding	IQCF5 MYH9 MYH10 MYO1A ADD2 CAMSAP1 RGS1 ITPKC MYO15A KCNH5	1.28e-04	230	203	10	GO:0005516
GeneOntologyMolecularFunction	histone reader activity	ZZEF1 JARID2 BRD4 PHF14	1.30e-04	26	203	4	GO:0140566
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH9 MYH10 MYO1A DNAH5 APPBP2 MYO19 MYO15A	2.06e-04	118	203	7	GO:0003774
GeneOntologyMolecularFunction	beta-adrenergic receptor kinase activity	GRK2 GRK3	6.09e-04	4	203	2	GO:0047696
GeneOntologyMolecularFunction	allyl-alcohol dehydrogenase activity	AKR1B10 AKR1B1	6.09e-04	4	203	2	GO:0047655
GeneOntologyMolecularFunction	AMPA glutamate receptor activity	GRIA1 GRIA4	6.09e-04	4	203	2	GO:0004971
GeneOntologyMolecularFunction	glutamate-gated receptor activity	GRIA1 GRIA4 GRIK3	6.34e-04	17	203	3	GO:0004970
GeneOntologyMolecularFunction	cyclic nucleotide binding	PDE4B PRKAR1B PDE5A PRKG1	6.46e-04	39	203	4	GO:0030551
GeneOntologyMolecularFunction	chromatin-protein adaptor activity	ZZEF1 JARID2 BRD4 PHF14	7.82e-04	41	203	4	GO:0140463
GeneOntologyMolecularFunction	lamin binding	HNRNPK SYNE1 PPP4C	8.90e-04	19	203	3	GO:0005521
GeneOntologyMolecularFunction	cytoskeleton-nuclear membrane anchor activity	SYNE2 SYNE1	1.01e-03	5	203	2	GO:0140444
GeneOntologyMolecularFunction	protein serine kinase activity	CDK9 SMG1 MARK1 CDKL3 MAST2 MELK AURKC BMP2K LMTK2 MTOR PRKG1	1.27e-03	363	203	11	GO:0106310
GeneOntologyCellularComponent	ionotropic glutamate receptor complex	LRRTM4 GRIA1 GRIA4 GRIK3 SACM1L	6.99e-05	45	201	5	GO:0008328
GeneOntologyCellularComponent	Cul2-RING ubiquitin ligase complex	FEM1C APPBP2 ZSWIM5 PRAMEF19 PRAMEF18	8.64e-05	47	201	5	GO:0031462
GeneOntologyCellularComponent	neurotransmitter receptor complex	LRRTM4 GRIA1 GRIA4 GRIK3 SACM1L	1.17e-04	50	201	5	GO:0098878
GeneOntologyCellularComponent	AMPA glutamate receptor complex	LRRTM4 GRIA1 GRIA4 SACM1L	1.87e-04	30	201	4	GO:0032281
GeneOntologyCellularComponent	cullin-RING ubiquitin ligase complex	FEM1C DDB1 APPBP2 ZSWIM5 PRAMEF19 FBXL17 PRAMEF18 FBH1 FBXL20	2.20e-04	212	201	9	GO:0031461
GeneOntologyCellularComponent	myosin complex	MYH9 MYH10 MYO1A MYO19 MYO15A	2.57e-04	59	201	5	GO:0016459
GeneOntologyCellularComponent	myosin II filament	MYH9 MYH10	2.74e-04	3	201	2	GO:0097513
GeneOntologyCellularComponent	glutamatergic synapse	MYH10 MARK1 HNRNPM DPYSL5 DAB1 HNRNPK ADD2 DACT1 GRK2 GRK3 LRRTM4 VPS26B GRIA1 GRIA4 GRIK3 SACM1L MTOR PRKAR1B FBXL20	3.56e-04	817	201	19	GO:0098978
GeneOntologyCellularComponent	plasma membrane raft	MYO1A INSR ADD2 DLC1 GRK2 LIPE CDH15	5.61e-04	147	201	7	GO:0044853
GeneOntologyCellularComponent	brush border	MYH9 MYH10 MYO1A DAB1 DIAPH1 VIL1 SLC9A2	6.84e-04	152	201	7	GO:0005903
GeneOntologyCellularComponent	transferase complex	CDK9 INSR FEM1C TRRAP DDB1 F13B JARID2 SUGT1 UVRAG APPBP2 ZSWIM5 PRAMEF19 FBXL17 PRAMEF18 POLR3A FBH1 BRD4 PRKAR1B TAF5L FBXL20	1.03e-03	963	201	20	GO:1990234
GeneOntologyCellularComponent	cell leading edge	MYH9 MYH10 MYO1A INSR DDX3X DLC1 ARHGAP31 SYNE2 DIAPH1 PLA2G4F VIL1 GRIA1 PSD4	1.15e-03	500	201	13	GO:0031252
HumanPheno	Short attention span	DDB1 HNRNPK JARID2 SATB1 VPS13A FGFR3 SYNE1 CASP2 GRIA1 GRIA4 ADNP ATP10A JMJD1C WDPCP PIEZO2 BRD4 PRKAR1B ANKRD17 KCNH5	1.06e-05	517	64	19	HP:0000736
HumanPheno	Reduced attention regulation	DDB1 HNRNPK JARID2 SATB1 VPS13A FGFR3 SYNE1 CASP2 GRIA1 GRIA4 ADNP ATP10A JMJD1C WDPCP PIEZO2 BRD4 PRKAR1B ANKRD17 KCNH5	1.36e-05	526	64	19	HP:5200044
MousePheno	abnormal cell motility	KDM3A MYH9 MYH10 PDE4B DOCK11 DAB1 TTC6 DLC1 GLG1 SYNE2 VPS13A DIAPH1 C2CD6 CAMSAP1 TRIM36 PREX1 ITPRIPL1 WDR62 GNPAT BICD2 APAF1 LHX6 RGS1 WDPCP LIPE BAZ1A MTOR	2.61e-06	885	160	27	MP:0020846
MousePheno	abnormal cell migration	MYH9 MYH10 PDE4B DOCK11 DAB1 DLC1 GLG1 SYNE2 DIAPH1 CAMSAP1 PREX1 GNPAT BICD2 APAF1 LHX6 RGS1 WDPCP MTOR	1.73e-05	501	160	18	MP:0003091
Domain	Kinase-like_dom	CDK9 SMG1 MARK1 INSR CDKL3 MAST2 TRRAP MELK AURKC GRK2 GRK3 ACAD11 ETNK1 FGFR3 BMP2K LMTK2 MTOR PRKG1	2.26e-05	542	200	18	IPR011009
Domain	FAT	SMG1 TRRAP MTOR	2.36e-05	6	200	3	PS51189
Domain	FATC	SMG1 TRRAP MTOR	2.36e-05	6	200	3	PS51190
Domain	FATC_dom	SMG1 TRRAP MTOR	2.36e-05	6	200	3	IPR003152
Domain	PIK_FAT	SMG1 TRRAP MTOR	2.36e-05	6	200	3	IPR014009
Domain	FATC	SMG1 TRRAP MTOR	2.36e-05	6	200	3	SM01343
Domain	Myosin_head_motor_dom	MYH9 MYH10 MYO1A MYO19 MYO15A	5.04e-05	38	200	5	IPR001609
Domain	MYOSIN_MOTOR	MYH9 MYH10 MYO1A MYO19 MYO15A	5.04e-05	38	200	5	PS51456
Domain	Myosin_head	MYH9 MYH10 MYO1A MYO19 MYO15A	5.04e-05	38	200	5	PF00063
Domain	MYSc	MYH9 MYH10 MYO1A MYO19 MYO15A	5.04e-05	38	200	5	SM00242
Domain	SPIN-2	SPIN2A SPIN2B	1.14e-04	2	200	2	IPR029564
Domain	IQ	IQCF5 MYH9 MYH10 MYO1A MYO19 MYO15A	2.33e-04	81	200	6	SM00015
Domain	FA	FRMD7 EPB41L1 EPB41L2	3.20e-04	13	200	3	PF08736
Domain	FERM-adjacent	FRMD7 EPB41L1 EPB41L2	3.20e-04	13	200	3	IPR014847
Domain	FA	FRMD7 EPB41L1 EPB41L2	3.20e-04	13	200	3	SM01195
Domain	TPR_REGION	FEM1C ST13 TTC6 SUGT1 VPS13A APPBP2 ZC3H7A EMC2	4.11e-04	165	200	8	PS50293
Domain	TPR	FEM1C ST13 TTC6 SUGT1 VPS13A APPBP2 ZC3H7A EMC2	4.11e-04	165	200	8	PS50005
Domain	IQ_motif_EF-hand-BS	IQCF5 MYH9 MYH10 MYO1A MYO19 MYO15A	4.13e-04	90	200	6	IPR000048
Domain	IQ	IQCF5 MYH9 MYH10 MYO1A MYO19 MYO15A	4.92e-04	93	200	6	PS50096
Domain	-	SMG1 TRRAP MTOR	6.11e-04	16	200	3	1.10.1070.11
Domain	PI3Kc	SMG1 TRRAP MTOR	6.11e-04	16	200	3	SM00146
Domain	KASH	SYNE2 SYNE1	6.75e-04	4	200	2	IPR012315
Domain	4_1_CTD	EPB41L1 EPB41L2	6.75e-04	4	200	2	PF05902
Domain	KASH	SYNE2 SYNE1	6.75e-04	4	200	2	PS51049
Domain	SAB	EPB41L1 EPB41L2	6.75e-04	4	200	2	PF04382
Domain	KASH	SYNE2 SYNE1	6.75e-04	4	200	2	SM01249
Domain	KASH	SYNE2 SYNE1	6.75e-04	4	200	2	PF10541
Domain	Band_4.1_C	EPB41L1 EPB41L2	6.75e-04	4	200	2	IPR008379
Domain	SAB_dom	EPB41L1 EPB41L2	6.75e-04	4	200	2	IPR007477
Domain	RGS	MYH9 GRK2 GRK3 RGS1	7.83e-04	39	200	4	IPR016137
Domain	Lig_chan-Glu_bd	GRIA1 GRIA4 GRIK3	8.77e-04	18	200	3	PF10613
Domain	PI3_PI4_kinase	SMG1 TRRAP MTOR	8.77e-04	18	200	3	PF00454
Domain	Glu/Gly-bd	GRIA1 GRIA4 GRIK3	8.77e-04	18	200	3	IPR019594
Domain	Lig_chan-Glu_bd	GRIA1 GRIA4 GRIK3	8.77e-04	18	200	3	SM00918
Domain	PI3_4_KINASE_1	SMG1 TRRAP MTOR	8.77e-04	18	200	3	PS00915
Domain	PI3_4_KINASE_2	SMG1 TRRAP MTOR	8.77e-04	18	200	3	PS00916
Domain	Iontro_rcpt	GRIA1 GRIA4 GRIK3	8.77e-04	18	200	3	IPR001320
Domain	PI3/4_kinase_cat_dom	SMG1 TRRAP MTOR	8.77e-04	18	200	3	IPR000403
Domain	Iono_rcpt_met	GRIA1 GRIA4 GRIK3	8.77e-04	18	200	3	IPR001508
Domain	PI3_4_KINASE_3	SMG1 TRRAP MTOR	8.77e-04	18	200	3	PS50290
Domain	Lig_chan	GRIA1 GRIA4 GRIK3	8.77e-04	18	200	3	PF00060
Domain	PBPe	GRIA1 GRIA4 GRIK3	8.77e-04	18	200	3	SM00079
Domain	TPR-like_helical_dom	FEM1C TRRAP ST13 TTC6 SUGT1 APPBP2 ZC3H7A MTOR EMC2	9.41e-04	233	200	9	IPR011990
Domain	IQ	IQCF5 MYH9 MYH10 MYO1A MYO15A	9.84e-04	71	200	5	PF00612
Domain	KA1	MARK1 MELK	1.12e-03	5	200	2	PF02149
Domain	SPIN/Ssty	SPIN2A SPIN2B	1.12e-03	5	200	2	IPR003671
Domain	KA1_dom	MARK1 MELK	1.12e-03	5	200	2	IPR001772
Domain	Spin-Ssty	SPIN2A SPIN2B	1.12e-03	5	200	2	PF02513
Domain	FATC	SMG1 MTOR	1.12e-03	5	200	2	PF02260
Domain	KA1	MARK1 MELK	1.12e-03	5	200	2	PS50032
Domain	-	MARK1 MELK	1.12e-03	5	200	2	3.30.310.80
Domain	TPR-contain_dom	ST13 TTC6 SUGT1 VPS13A APPBP2 ZC3H7A EMC2	1.18e-03	150	200	7	IPR013026
Domain	PROTEIN_KINASE_ATP	CDK9 MARK1 INSR CDKL3 MAST2 MELK AURKC GRK2 GRK3 FGFR3 BMP2K LMTK2 PRKG1	1.39e-03	459	200	13	PS00107
Domain	Ez/rad/moesin-like	FRMD7 EPB41L1 EPB41L2	1.40e-03	21	200	3	IPR000798
Domain	FERM_M	FRMD7 MYO15A EPB41L1 EPB41L2	1.46e-03	46	200	4	PF00373
Domain	FAT	TRRAP MTOR	1.66e-03	6	200	2	PF02259
Domain	PIK-rel_kinase_FAT	TRRAP MTOR	1.66e-03	6	200	2	IPR003151
Domain	-	FEM1C TRRAP ST13 SUGT1 APPBP2 ZC3H7A MTOR EMC2	1.79e-03	207	200	8	1.25.40.10
Domain	FERM_central	FRMD7 MYO15A EPB41L1 EPB41L2	1.86e-03	49	200	4	IPR019748
Domain	FERM_domain	FRMD7 MYO15A EPB41L1 EPB41L2	1.86e-03	49	200	4	IPR000299
Domain	FERM_1	FRMD7 MYO15A EPB41L1 EPB41L2	2.00e-03	50	200	4	PS00660
Domain	FERM_2	FRMD7 MYO15A EPB41L1 EPB41L2	2.00e-03	50	200	4	PS00661
Domain	FERM_3	FRMD7 MYO15A EPB41L1 EPB41L2	2.00e-03	50	200	4	PS50057
Domain	Band_41_domain	FRMD7 MYO15A EPB41L1 EPB41L2	2.00e-03	50	200	4	IPR019749
Domain	B41	FRMD7 MYO15A EPB41L1 EPB41L2	2.00e-03	50	200	4	SM00295
Domain	JmjC	KDM3A JARID2 JMJD1C	2.07e-03	24	200	3	PF02373
Domain	FERM_CS	FRMD7 EPB41L1 EPB41L2	2.07e-03	24	200	3	IPR019747
Domain	KA1/Ssp2_C	MARK1 MELK	2.31e-03	7	200	2	IPR028375
Domain	GPCR_kinase	GRK2 GRK3	2.31e-03	7	200	2	IPR000239
Domain	Prot_kinase_dom	CDK9 MARK1 INSR CDKL3 MAST2 MELK AURKC GRK2 GRK3 FGFR3 BMP2K LMTK2 PRKG1	2.42e-03	489	200	13	IPR000719
Domain	PROTEIN_KINASE_DOM	CDK9 MARK1 INSR CDKL3 MAST2 MELK AURKC GRK2 GRK3 FGFR3 BMP2K LMTK2 PRKG1	2.60e-03	493	200	13	PS50011
Domain	FERM_C	FRMD7 EPB41L1 EPB41L2	2.62e-03	26	200	3	PF09380
Domain	Protein_kinase_ATP_BS	CDK9 MARK1 INSR CDKL3 MELK AURKC GRK2 GRK3 FGFR3 LMTK2 PRKG1	2.66e-03	379	200	11	IPR017441
Domain	FERM_PH-like_C	FRMD7 EPB41L1 EPB41L2	2.93e-03	27	200	3	IPR018980
Domain	FERM_C	FRMD7 EPB41L1 EPB41L2	2.93e-03	27	200	3	SM01196
Domain	AGC-kinase_C	MAST2 GRK2 GRK3 PRKG1	3.03e-03	56	200	4	IPR000961
Domain	AGC_KINASE_CTER	MAST2 GRK2 GRK3 PRKG1	3.03e-03	56	200	4	PS51285
Domain	S_TK_X	MAST2 GRK2 GRK3 PRKG1	3.03e-03	56	200	4	SM00133
Domain	PyrdxlP-dep_de-COase	PDXDC1 GAD2	3.06e-03	8	200	2	IPR002129
Domain	Pyridoxal_deC	PDXDC1 GAD2	3.06e-03	8	200	2	PF00282
Domain	DDC_GAD_HDC_YDC	PDXDC1 GAD2	3.06e-03	8	200	2	PS00392
Pubmed	Proteomic analysis of an interactome for long-form AMPA receptor subunits.	MYH9 MYH10 HNRNPM DDX3X HNRNPK GRIA1 GRIA4	1.29e-12	15	203	7	20131911
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	MYH9 MYH10 HNRNPM ANKHD1 MAST2 DDB1 ST13 NDUFV1 DDX1 DDX3X HNRNPK JARID2 UTP15 DIAPH1 CC2D2A AKR1B1 DNAH5 IMMT SYNE1 GEMIN5 ADNP YARS1 POLR3A SACM1L BAZ1A MTOR TAF5L CDC5L EMC2 TOP2A RBM34 EPB41L2	6.49e-11	1425	203	32	30948266
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CDK9 PLCXD1 HNRNPM ANKHD1 MAST2 ZZEF1 TRRAP DDB1 INO80D AURKC ACAD11 DIAPH1 WDR62 ARAP2 TOR1AIP2 SETD2 DPF3 BRD4 ANKRD17 TAF5L CSMD1 PADI2 TOP2A PCID2 CDH15	1.02e-08	1116	203	25	31753913
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MYH9 MYH10 PDE4B DOCK11 HNRNPM DDB1 DDX3X HNRNPK SYNE2 DIAPH1 CAMSAP1 SYNE1 GRIA1 GRIA4 GRIK3 ADNP ZBTB1 MTOR PRKAR1B ANKRD17 CDC5L EPB41L1 EPB41L2	1.29e-08	963	203	23	28671696
Pubmed	Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing.	HNRNPM DDX1 HNRNPK GEMIN5 TOP2A	2.67e-08	16	203	5	16230076
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CDK9 DOCK11 DPYSL5 MAST2 MELK DDX1 DDX3X DLC1 SYNE2 CAMSAP1 HECTD1 UVRAG WDR62 ARAP2 DOP1B LMTK2 MTOR BRD4 ANKRD17 EPB41L1 EPB41L2	4.05e-08	861	203	21	36931259
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	SMG1 DOCK11 HNRNPM TRRAP DDX3X CAMSAP1 HECTD1 LMTK2 GEMIN5 ADNP ZBTB1 SETD2 PPP4C ANKRD17 TOP2A	5.69e-08	440	203	15	34244565
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MYH9 MYH10 MARK1 HNRNPM DPYSL5 PHYHIP DDB1 ST13 NDUFV1 DDX1 HNRNPK ADD2 TBC1D24 GRK2 SACS AKR1B10 AKR1B1 METAP2 IMMT SYNE1 GEMIN5 GRIA1 YARS1 SACM1L CDC5L EPB41L1 EPB41L2	8.61e-08	1431	203	27	37142655
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	IQCF5 SMG1 MYH9 MYH10 MYO1A PDGFA HNRNPM DDX1 SACS SYNE2 VPS13A CC2D2A PREX1 IMMT VIL1 ZSWIM5 SYNE1 GRIA1 GRIA4 ZC3H7A BAZ1A CFAP74 PHF14 MYOM2 EMC2 TOP2A PCID2	1.00e-07	1442	203	27	35575683
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MYH9 MYH10 HNRNPM ANKHD1 TRRAP MELK DDB1 DDX1 HNRNPK SUGT1 UTP15 DIAPH1 METAP2 IMMT MYO19 GEMIN5 ADNP POLR3A ZC3H7A BAZ1A ANKRD17 CDC5L TOP2A PCID2 RBM34 EPB41L2	1.07e-07	1353	203	26	29467282
Pubmed	Regulation of AMPA receptor GluR1 subunit surface expression by a 4. 1N-linked actin cytoskeletal association.	GRIA1 EPB41L1 EPB41L2	1.96e-07	3	203	3	11050113
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	CDK9 HNRNPM ANKHD1 TRRAP DDX3X HNRNPK SUGT1 UTP15 DNAH5 VPS26B APAF1 POLR3A SACM1L PPP4C MTOR ANKRD17 TOP2A EPB41L2	1.99e-07	704	203	18	29955894
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	MYH9 MYH10 HNRNPM DAB1 FEM1C ANKHD1 DDB1 F13B CC2D2A AKR1B1 ZSWIM5 PRAMEF19 PRAMEF18 YARS1 ANKRD17 MYO15A	2.47e-07	564	203	16	21565611
Pubmed	ZF21 is a new regulator of focal adhesion disassembly and a potential member of the spreading initiation center.	MYH9 MYH10 HNRNPM DDX1 DDX3X HNRNPK	2.83e-07	46	203	6	20890123
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	MYH9 MYH10 HNRNPM DDB1 DDX1 DDX3X HNRNPK GEMIN5 PARP14 FBH1 CDC5L TOP2A	8.70e-07	340	203	12	24332808
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	GAD2 MYH9 MYH10 MARK1 HNRNPM ST13 NDUFV1 TBC1D24 GRK2 SUGT1 GLG1 CAMSAP1 BICD2 LMTK2 GRIA1 GRIA4 YARS1 SACM1L PRKAR1B EMC2 EPB41L1 EPB41L2	1.01e-06	1139	203	22	36417873
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	MYH9 ANKHD1 SATB1 CAMSAP1 WDR62 TANGO6 BICD2 GEMIN5 ADNP ZBTB1 JMJD1C BRD4 ANKRD17	1.25e-06	418	203	13	34709266
Pubmed	Systematic Determination of Human Cyclin Dependent Kinase (CDK)-9 Interactome Identifies Novel Functions in RNA Splicing Mediated by the DEAD Box (DDX)-5/17 RNA Helicases.	CDK9 MYH9 MYH10 HNRNPM DDX3X HNRNPK AKR1B10 IMMT VIL1 CDC5L RBM34	1.48e-06	295	203	11	26209609
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SMG1 ANKHD1 MAST2 ZZEF1 DDX1 DDX3X ACAD11 RNF128 GNPAT MYO19 JMJD1C POLR3A SACM1L IBTK ANKRD17 EPB41L1	1.59e-06	650	203	16	38777146
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CDK9 MYH9 MYH10 MARK1 HNRNPM DPYSL5 TRRAP DDB1 NDUFV1 DDX1 DDX3X HNRNPK ADD2 SACS SYNE1 ADNP SACM1L SETD2 BRD4 TAF5L CDC5L	1.68e-06	1082	203	21	38697112
Pubmed	Expression and heteromeric interactions of non-N-methyl-D-aspartate glutamate receptor subunits in the developing and adult cerebellum.	GRIA1 GRIA4 GRIK3	1.94e-06	5	203	3	9466455
Pubmed	Surface expression of GluR-D AMPA receptor is dependent on an interaction between its C-terminal domain and a 4.1 protein.	GRIA1 GRIA4 EPB41L1	1.94e-06	5	203	3	12574408
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	KDM3A GAD2 CRIM1 ST13 DDX3X HNRNPK SATB1 SACS HECTD1 METAP2 UAP1L1 PREX1 IMMT DOP1B BICD2 SYNE1 YARS1 TMED4 VPS9D1 FBH1 NECAB3 TNKS2 PADI2	2.05e-06	1285	203	23	35914814
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	CDK9 MYH9 TRRAP DDB1 DDX1 DIAPH1 AKR1B1 IMMT GEMIN5 ADNP YARS1 POLR3A SETD2 PPP4C BAZ1A BRD4 PHF14 CDC5L MYO15A TOP2A	2.36e-06	1014	203	20	32416067
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	MYH9 HNRNPM TRRAP DDB1 DDX3X HNRNPK PARP14 SETD2 CDC5L TOP2A	2.39e-06	250	203	10	33536335
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	PDXDC1 MYH9 MYH10 ANKHD1 TRRAP MELK NDUFV1 DDX3X SUGT1 GLG1 SYNE2 DIAPH1 HECTD1 METAP2 TOR1AIP2 GEMIN5 YARS1 TMED4 SACM1L BAZ1A PCID2 RBM34 EPB41L2	2.40e-06	1297	203	23	33545068
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	CDK9 MYH9 MYH10 DDB1 DDX3X SYNE2 BMP2K SYNE1 MYOM2	2.62e-06	197	203	9	20811636
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	MYH9 MYH10 HNRNPM ANKHD1 DDB1 DDX3X HNRNPK SUGT1 CAMSAP1 WDR62 GEMIN5 ADNP IBTK SETD2 BAZ1A ANKRD17 CDC5L TOP2A EPB41L2	2.75e-06	934	203	19	33916271
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SMG1 KDM3A FEM1C ANKHD1 ZZEF1 MELK TBC1D24 ARHGAP31 LMTK2 ADNP IBTK ANKRD17 PADI2 MINDY1	3.18e-06	529	203	14	14621295
Pubmed	Vulnerability of white matter towards antenatal hypoxia is linked to a species-dependent regulation of glutamate receptor subunits.	GRIA1 GRIA4 GRIK3	3.87e-06	6	203	3	18922769
Pubmed	The TRPM7 chanzyme is cleaved to release a chromatin-modifying kinase.	MYH9 DDB1 DDX3X	3.87e-06	6	203	3	24855944
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	CDK9 SYNE2 DIAPH1 IMMT GNPAT TANGO6 GEMIN5 JMJD1C BRD4 TAF5L TNKS2 MYO15A	4.42e-06	398	203	12	35016035
Pubmed	ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.	MYH9 MYH10 HNRNPM DDB1 DDX1 DDX3X AKR1B10 IMMT BMP2K IBTK	4.43e-06	268	203	10	33024031
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	PDXDC1 HNRNPM ANKHD1 DDB1 NDUFV1 DDX3X HNRNPK GLG1 DIAPH1 METAP2 IMMT VIL1 PARP14 YARS1 PCID2 RBM34	4.97e-06	711	203	16	33022573
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	MYH9 MYH10 ANKHD1 ST13 POLR3A MTOR ANKRD17 CDC5L EPB41L2	5.34e-06	215	203	9	35973513
Pubmed	Defining the membrane proteome of NK cells.	CDK9 KDM3A MYH9 MFSD6 HNRNPM MELK DDX1 HNRNPK GRK2 GLG1 ETNK1 IMMT ITPRIPL1 GNPAT GEMIN5 PARP14 POLR3A MTOR ANKRD17 CDC5L PSD4	5.48e-06	1168	203	21	19946888
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	PDXDC1 MYH10 HNRNPM DDB1 ST13 DDX1 DDX3X HNRNPK DIAPH1 HECTD1 IMMT GEMIN5 MTOR CDC5L EPB41L2	5.90e-06	638	203	15	33239621
Pubmed	A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.	CDK9 MYH9 HNRNPM DDX1 DDX3X	6.52e-06	45	203	5	25496916
Pubmed	A new role for the architecture of microvillar actin bundles in apical retention of membrane proteins.	MYH9 MYH10 MYO1A DIAPH1 VIL1	6.52e-06	45	203	5	22114352
Pubmed	Glutamate receptors in cortical plasticity: molecular and cellular biology.	GRIA1 GRIA4 GRIK3	6.74e-06	7	203	3	9016303
Pubmed	Glutamate receptors: brain function and signal transduction.	GRIA1 GRIA4 GRIK3	6.74e-06	7	203	3	9651535
Pubmed	Primary structure and expression of the gamma 2 subunit of the glutamate receptor channel selective for kainate.	GRIA1 GRIA4 GRIK3	6.74e-06	7	203	3	1310861
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	PDXDC1 FRMD7 ADD2 TBC1D24 ARHGAP31 CAMSAP1 MYRF ARAP2 PARP14 PIEZO2 MTOR EPB41L1 EPB41L2 PSD4	7.30e-06	569	203	14	30639242
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MARK1 FAT2 SACS HECTD1 PREX1 TANGO6 ATP10A JMJD1C SETD2 GLCE PHF14 CDC5L EMC2	7.49e-06	493	203	13	15368895
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	PDC MYH9 DOCK11 HNRNPM ZZEF1 HNRNPK VPS13A ITPRIPL1 DOP1B VIL1 APPBP2 MYO19 PARP14 PHF14 RBM43 EPB41L2	7.66e-06	736	203	16	29676528
Pubmed	TRIM24 is an insulin-responsive regulator of P-bodies.	MYH10 HNRNPM ANKHD1 IMMT ANKRD17 TOP2A	7.70e-06	80	203	6	35803934
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYH9 MYH10 ANKHD1 TRRAP DDB1 UTP15 SYNE2 HECTD1 IMMT GEMIN5 ADNP MTOR ANKRD17 RBM34 EPB41L2	7.77e-06	653	203	15	22586326
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	KDM3A MYH9 MYH10 MYO1A MARK1 FEM1C TRRAP MELK SUGT1 YAE1 HECTD1 IMMT BICD2 TOR1AIP2 USP49 POLR3A ANKRD17 TAF5L GPN3	7.80e-06	1005	203	19	19615732
Pubmed	SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.	PDXDC1 MYH9 HNRNPM ZZEF1 DDB1 ST13 DDX3X HNRNPK VPS13A IMMT GEMIN5 YARS1 MTOR EMC2 GPN3	8.35e-06	657	203	15	36180527
Pubmed	Identification of proteins interacting with protein arginine methyltransferase 8: the Ewing sarcoma (EWS) protein binds independent of its methylation state.	DDX1 DDX3X HNRNPK SYNE2	9.15e-06	23	203	4	18320585
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	MYH9 MYH10 DAB1 DDX3X SYNE2 FGFR3 CASP2 MTOR PRKG1 CDC5L TOP2A	9.33e-06	358	203	11	32460013
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	MAST2 DDX3X HNRNPK FGFR3 CAMSAP1 GEMIN5 ATP10A JMJD1C ZNF529 LRRC52 BAZ1A	1.01e-05	361	203	11	26167880
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	HNRNPM MAST2 DDX3X FAT2 CAMSAP1 DNAH5 SYNE1 CDC5L TOP2A	1.05e-05	234	203	9	36243803
Pubmed	A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways.	CDK9 HNRNPM ST13 SUGT1 ACAD11 SYNE2 FGFR3 HECTD1 USP49 POLR3A MYO15A	1.06e-05	363	203	11	25036637
Pubmed	Association analysis of the glutamic acid decarboxylase 2 and the glutamine synthetase genes (GAD2, GLUL) with schizophrenia.	GAD2 GRIA4 GRIK3	1.07e-05	8	203	3	19125103
Pubmed	Transmembrane topology of the glutamate receptor subunit GluR6.	GRIA1 GRIA4 GRIK3	1.07e-05	8	203	3	8163463
Pubmed	High-resolution proteomics unravel architecture and molecular diversity of native AMPA receptor complexes.	LRRTM4 GRIA1 GRIA4 SACM1L	1.09e-05	24	203	4	22632720
Pubmed	ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers.	MYH9 MYH10 DDB1 DDX3X CDC5L	1.10e-05	50	203	5	37001908
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	HNRNPM TRRAP DDB1 DDX1 HNRNPK ACAD11 UTP15 HECTD1 ZC3H7A IBTK BAZ1A CDC5L EFCAB7 TOP2A PCID2 RBM34	1.12e-05	759	203	16	35915203
Pubmed	Global Interactome Mapping of Mitochondrial Intermembrane Space Proteases Identifies a Novel Function for HTRA2.	MYH10 ZZEF1 NDUFV1 SUGT1 VPS13A DIAPH1 HECTD1 IMMT WDR62 DOP1B VPS26B PPP4C GPN3	1.19e-05	515	203	13	31617661
Pubmed	HDAC6 activity is not required for basal autophagic flux in metastatic prostate cancer cells.	MYH9 MYH10 TRRAP DDX3X HNRNPK	1.34e-05	52	203	5	26643866
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	HNRNPM MAST2 ZZEF1 TRRAP SYNE2 SYNE1 PARP14 SETD2	1.53e-05	187	203	8	26460568
Pubmed	Expression of glutamate receptor subunit genes during development of the mouse retina.	GRIA1 GRIA4 GRIK3	1.60e-05	9	203	3	9051806
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	HNRNPM DDB1 ST13 NDUFV1 ADD2 SUGT1 UTP15 SACS GLG1 SYNE2 VPS13A IMMT WDR62 TOR1AIP2 SYNE1 APAF1 ZC3H7A PRKAR1B CDC5L EMC2 EPB41L1 RBM34 EPB41L2	2.17e-05	1487	203	23	33957083
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	MYH10 TRRAP DDB1 DDX1 YARS1 BAZ1A BRD4 PHF14 CDC5L TOP2A EPB41L2	2.26e-05	394	203	11	27248496
Pubmed	Tel2 regulates the stability of PI3K-related protein kinases.	SMG1 TRRAP MTOR	2.28e-05	10	203	3	18160036
Pubmed	ZAR1 and ZAR2 are required for oocyte meiotic maturation by regulating the maternal transcriptome and mRNA translational activation.	DDB1 PRAMEF19 PRAMEF18 CDC5L TOP2A	2.30e-05	58	203	5	31598710
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	PDXDC1 MYH10 ZZEF1 DDB1 ST13 NDUFV1 HNRNPK SUGT1 UTP15 SYNE2 VPS13A IMMT WDR62 TOR1AIP2 BMP2K SYNE1 MYO19 YARS1 POLR3A IBTK EMC2 TOP2A RBM34	2.38e-05	1496	203	23	32877691
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ANKHD1 TRRAP INO80D NDUFV1 JARID2 ACAD11 UTP15 GLG1 PREX1 IMMT FHIP1A BMP2K SYNE1 GEMIN5 ZC3H7A SETD2 BAZ1A ANKRD17 PHF14 TAF5L PCID2 EPB41L1 EPB41L2	2.41e-05	1497	203	23	31527615
Pubmed	The necdin interactome: evaluating the effects of amino acid substitutions and cell stress using proximity-dependent biotinylation (BioID) and mass spectrometry.	MYH9 MYH10 HNRNPM DDX1 DDX3X HNRNPK SUGT1 AKR1B1 YARS1 TOP2A	2.69e-05	330	203	10	32529326
Pubmed	A protein interaction network for Ecm29 links the 26 S proteasome to molecular motors and endosomal components.	MYH10 HNRNPM SYNE1 TMED4 ANKRD17	2.71e-05	60	203	5	20682791
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	KDM3A MAST2 SACS SYNE1 ADNP PHF14	2.94e-05	101	203	6	9872452
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	CDK9 MYH9 MYH10 HNRNPM ANKHD1 DDB1 DDX1 DDX3X HNRNPK GLG1 SYNE2 DIAPH1 HECTD1 METAP2 IMMT GEMIN5 YARS1 CDC5L EMC2 GPN3 TOP2A EPB41L2	3.07e-05	1415	203	22	28515276
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	DLC1 TANGO6 SYNE1 SACM1L SETD2 CFAP74	3.10e-05	102	203	6	11214970
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SYNE2 VPS13A MYRF DOP1B ZBTB1 PADI2	3.10e-05	102	203	6	10231032
Pubmed	Identification of new high affinity targets for Roquin based on structural conservation.	DDX1 GEMIN5 ZC3H7A	3.12e-05	11	203	3	30295819
Pubmed	Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly.	SMG1 TRRAP MTOR	3.12e-05	11	203	3	20427287
Pubmed	BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs.	HNRNPK SATB1 IBTK TOP2A	3.13e-05	31	203	4	23086144
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	MYH9 MYH10 HNRNPM ST13 DDX1 DDX3X HNRNPK ADD2 UTP15 DIAPH1 METAP2 BMP2K GEMIN5 ADNP YARS1 CDC5L GPN3 TOP2A PCID2 TUBAL3 RBM34	3.30e-05	1318	203	21	30463901
Pubmed	Metabolic stress activates an ERK/hnRNPK/DDX3X pathway in pancreatic β cells.	DDX3X HNRNPK	3.39e-05	2	203	2	31178390
Pubmed	Aldose reductase (AC)n gene polymorphism and susceptibility to diabetic retinopathy in Type 2 diabetes in Caucasians.	AKR1B10 AKR1B1	3.39e-05	2	203	2	15745835
Pubmed	Nesprins: a novel family of spectrin-repeat-containing proteins that localize to the nuclear membrane in multiple tissues.	SYNE2 SYNE1	3.39e-05	2	203	2	11792814
Pubmed	The function of the chemokine receptor CXCR6 in the T cell response of mice against Listeria monocytogenes.	RAG1 CXCR6	3.39e-05	2	203	2	24832098
Pubmed	Alterations in the expression of DEAD-box and other RNA binding proteins during HIV-1 replication.	DDX1 DDX3X	3.39e-05	2	203	2	15588285
Pubmed	Mutations in non-muscle myosin 2A disrupt the actomyosin cytoskeleton in Sertoli cells and cause male infertility.	MYH9 MYH10	3.39e-05	2	203	2	33188738
Pubmed	An RNA helicase, DDX1, interacting with poly(A) RNA and heterogeneous nuclear ribonucleoprotein K.	DDX1 HNRNPK	3.39e-05	2	203	2	12183465
Pubmed	Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks.	AKR1B10 AKR1B1	3.39e-05	2	203	2	33945128
Pubmed	Nonmuscle myosin IIA and IIB differentially contribute to intrinsic and directed migration of human embryonic lung fibroblasts.	MYH9 MYH10	3.39e-05	2	203	2	29486156
Pubmed	Decreased levels of AKR1B1 and AKR1B10 in cancerous endometrium compared to adjacent non-cancerous tissue.	AKR1B10 AKR1B1	3.39e-05	2	203	2	23146748
Pubmed	Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions.	PDE5A PRKG1	3.39e-05	2	203	2	18757735
Pubmed	Arginine Methylation of hnRNPK Inhibits the DDX3-hnRNPK Interaction to Play an Anti-Apoptosis Role in Osteosarcoma Cells.	DDX3X HNRNPK	3.39e-05	2	203	2	34575922
Pubmed	Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.	PDE5A PRKG1	3.39e-05	2	203	2	17420342
Pubmed	Expression of four myosin heavy chain isoforms with development in mouse uterus.	MYH9 MYH10	3.39e-05	2	203	2	8402956
Pubmed	Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease.	MYH9 MYH10	3.39e-05	2	203	2	16596254
Pubmed	Cloning of GRK2 cDNA from S49 murine lymphoma cells.	GRK2 GRK3	3.39e-05	2	203	2	8638670
Pubmed	Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis.	JMJD1C MTOR	3.39e-05	2	203	2	32034158
Pubmed	Non-Muscle Myosin II Isoforms Have Different Functions in Matrix Rearrangement by MDA-MB-231 Cells.	MYH9 MYH10	3.39e-05	2	203	2	26136073
Pubmed	Dissecting the roles of GRK2 and GRK3 in μ-opioid receptor internalization and β-arrestin2 recruitment using CRISPR/Cas9-edited HEK293 cells.	GRK2 GRK3	3.39e-05	2	203	2	33060647
Pubmed	Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111).	AKR1B10 AKR1B1	3.39e-05	2	203	2	24100137
Pubmed	Differential expression and functions of cortical myosin IIA and IIB isotypes during meiotic maturation, fertilization, and mitosis in mouse oocytes and embryos.	MYH9 MYH10	3.39e-05	2	203	2	9725909
Interaction	GRIA4 interactions	MYH9 MYH10 HNRNPM DDX3X HNRNPK GRIA1 GRIA4 EPB41L1	5.90e-09	41	200	8	int:GRIA4
Interaction	SIRT6 interactions	SMG1 DOCK11 HNRNPM TRRAP DDB1 DDX3X HNRNPK CAMSAP1 HECTD1 LMTK2 GEMIN5 ADNP ZNF865 ZBTB1 SETD2 PPP4C BRD4 ANKRD17 EMC2 TOP2A	4.75e-06	628	200	20	int:SIRT6
Interaction	PPP1CA interactions	CDK9 MYH9 HNRNPM DDB1 ST13 DDX1 HNRNPK DIAPH1 PREX1 BMP2K MYO19 APAF1 LMTK2 POLR3A ZC3H7A IBTK BRD4 PDE5A CDC5L GPN3 TOP2A	6.25e-06	696	200	21	int:PPP1CA
Interaction	PRKACA interactions	GAD2 PDC MYH9 MYH10 PDE4B HNRNPM ADD2 DACT1 GRK2 AKR1B1 IMMT USP49 GRIA1 GRIA4 LIPE PRKAR1B TUBAL3	1.77e-05	519	200	17	int:PRKACA
Interaction	AURKB interactions	MYH9 MYH10 MYO1A HNRNPM ZZEF1 TRRAP HSP90AA5P DDB1 DDX1 HNRNPK AURKC SUGT1 HECTD1 WDR62 POLR3A SETD2 BRD4 ANKRD17 MYOM2 CDC5L TOP2A	2.38e-05	761	200	21	int:AURKB
Interaction	MKRN2 interactions	SMG1 MYH9 MYH10 DAB1 DDX3X SYNE2 FGFR3 APAF1 CASP2 ZC3H7A MTOR PRKG1 CDC5L TOP2A	3.24e-05	385	200	14	int:MKRN2
Interaction	ECPAS interactions	KDM3A IL13RA2 MYH10 DOCK11 HNRNPM TRRAP DDX1 FGFR3 SYNE1 TMED4 IBTK BRD4 ANKRD17	3.40e-05	337	200	13	int:ECPAS
Interaction	YWHAG interactions	CDK9 MYH10 DOCK11 MARK1 HNRNPM DPYSL5 MAST2 TRRAP MELK ST13 DDX1 DDX3X DLC1 SYNE2 CAMSAP1 HECTD1 UVRAG WDR62 ARAP2 LMTK2 BAZ1A MTOR ANKRD17 CDC5L EFCAB7 EPB41L1 EPB41L2 PSD4	4.42e-05	1248	200	28	int:YWHAG
Interaction	TUBB4B interactions	CDK9 MYH9 ANKHD1 TRRAP MELK HNRNPK CAMSAP1 HECTD1 WDR62 BICD2 GRIA4 ZBTB1 BRD4 CDC5L EMC2 EPB41L2 KCNH5	4.61e-05	560	200	17	int:TUBB4B
Interaction	KIF5B interactions	CDK9 MYH9 DDB1 ST13 DIAPH1 FHIP1A LMTK2 GEMIN5 GRIA1 BRD4 PRKAR1B CDC5L EPB41L1	4.73e-05	348	200	13	int:KIF5B
Interaction	RPA4 interactions	HNRNPM ANKHD1 TRRAP HNRNPK SUGT1 UTP15 PREX1 WDR62 BICD2 ADNP SETD2 MTOR CDC5L TOP2A EPB41L2	4.83e-05	452	200	15	int:RPA4
Interaction	TDRD3 interactions	SMG1 ST13 DDX1 DDX3X CC2D2A TRIM36 HECTD1 ZC3H7A IBTK ANKRD17	5.32e-05	212	200	10	int:TDRD3
Interaction	PPP1R12B interactions	MYH9 ANKHD1 MYO19 ANKRD17 PRKG1 TNKS2	5.82e-05	68	200	6	int:PPP1R12B
Interaction	CAPN6 interactions	SYNE2 HECTD1 BICD2 BAZ1A	7.19e-05	23	200	4	int:CAPN6
Interaction	STK36 interactions	CDK9 MAST2 TRRAP HSP90AA5P CDC5L	8.10e-05	45	200	5	int:STK36
Interaction	RFC4 interactions	CDK9 IL13RA2 HNRNPM TRRAP DDX1 HECTD1 PREX1 IBTK BRD4 CDC5L	9.40e-05	227	200	10	int:RFC4
Interaction	S100A4 interactions	MYH9 MYH10 ZZEF1 SUGT1 SATB1 SYNE2 METAP2 BRD4	9.72e-05	144	200	8	int:S100A4
Interaction	SRPK2 interactions	CDK9 HNRNPM MAST2 DDX3X HNRNPK FGFR3 CAMSAP1 HECTD1 PURG JMJD1C ZNF529 LRRC52 SETD2 BAZ1A CDC5L TOP2A EPB41L1 RBM34 EPB41L2	1.01e-04	717	200	19	int:SRPK2
Interaction	DSCR9 interactions	DDX3X HNRNPK IMMT BICD2 SYNE1 VPS9D1 FBH1 TNKS2	1.12e-04	147	200	8	int:DSCR9
Interaction	PTPRF interactions	IL13RA2 INSR TRRAP DDX1 HNRNPK GRK2 SUGT1 VPS13A DIAPH1 RNF128	1.17e-04	233	200	10	int:PTPRF
Interaction	ARHGEF15 interactions	TRRAP DDB1 SUGT1 BICD2 PRKG1	1.22e-04	49	200	5	int:ARHGEF15
Interaction	CT45A5 interactions	ANKHD1 GLG1 PPP4C BRD4 ANKRD17 PHF14	1.26e-04	78	200	6	int:CT45A5
Interaction	NPHP4 interactions	MYH9 MYH10 DAB1 FEM1C ANKHD1 DDB1 SUGT1 ZSWIM5 YARS1 TUBAL3	1.29e-04	236	200	10	int:NPHP4
Cytoband	Xp11.1	SPIN2A SPIN2B	1.17e-04	4	204	2	Xp11.1
GeneFamily	Ankyrin repeat domain containing	FEM1C ANKHD1 ASB8 HECTD1 ARAP2 ASB15 IBTK ANKRD17 TNKS2	1.27e-04	242	142	9	403
GeneFamily	Spectrin repeat containing nuclear envelope family	SYNE2 SYNE1	3.64e-04	4	142	2	1252
GeneFamily	Glutamate ionotropic receptor AMPA type subunits	GRIA1 GRIA4	3.64e-04	4	142	2	1200
GeneFamily	Erythrocyte membrane protein band 4.1\|FERM domain containing	EPB41L1 EPB41L2	3.64e-04	4	142	2	951
GeneFamily	Tudor domain containing\|Spindlin family	SPIN2A SPIN2B	6.03e-04	5	142	2	1089
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	FRMD7 MYO15A EPB41L1 EPB41L2	6.35e-04	50	142	4	1293
GeneFamily	Tudor domain containing	SPIN2A SPIN2B TDRD1	3.03e-03	37	142	3	780
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	KDM3A CRIM1 MAST2 ZZEF1 TRRAP MELK JARID2 DLC1 SACS SYNE2 VPS13A UVRAG ARAP2 DOP1B APPBP2 BMP2K ADNP IBTK SETD2 BAZ1A ANKRD17 PHF14 EMC2 TOP2A	5.33e-08	856	202	24	M4500
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	SMG1 CRIM1 ANKHD1 ST13 GRK3 SACS SYNE2 DIAPH1 SPIN2A ETNK1 CAMSAP1 SPIN2B ARAP2 GNPAT APPBP2 BMP2K APAF1 ADNP ATP10A RGS1 IBTK BAZ1A GLCE ANKRD17 EMC2	7.94e-06	1215	202	25	M41122
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	CRIM1 TRRAP MELK JARID2 DLC1 VPS13A UVRAG DOP1B APPBP2 IBTK SETD2 BAZ1A ANKRD17 TOP2A	1.70e-05	466	202	14	M13522
Coexpression	GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_DN	CDK9 HNRNPM ST13 BICD2 APPBP2 POLR3A IL1RL1 TNFAIP6 CSMD1	2.66e-05	200	202	9	M8225
Coexpression	ZHENG_BOUND_BY_FOXP3	KDM3A PDE4B FEM1C JARID2 SATB1 SYNE2 CC2D2A ETNK1 HECTD1 HJV ZBTB1 RGS1 JMJD1C IBTK	3.51e-05	498	202	14	M1741
Coexpression	HEVNER_CORTEX_INTERNEURON_PRECURSOR_CELLS	GAD2 GRIA1 GRIA4 LHX6	3.82e-05	25	202	4	MM400
Coexpression	ZHENG_BOUND_BY_FOXP3	KDM3A PDE4B FEM1C JARID2 SATB1 SYNE2 CC2D2A ETNK1 HECTD1 HJV ZBTB1 RGS1 JMJD1C IBTK	4.26e-05	507	202	14	MM1030
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	RERG MYH10 MARK1 SLCO1C1 SACS PDE5A MYOM2 PRKG1	1.39e-06	173	204	8	a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRIM1 SATB1 VPS13A DIAPH1 SPIN2A ARAP2 RGS1 CXCR6	2.03e-06	182	204	8	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRIM1 SATB1 VPS13A DIAPH1 SPIN2A ARAP2 RGS1 CXCR6	2.03e-06	182	204	8	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	UGT8 FGFR3 MYRF PREX1 PIEZO2 DPF3 PADI2 PSD4	2.29e-06	185	204	8	b5277190866d9eb5b85eceaa5ba116ea6e6f286b
ToppCell	COPD-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	CRIM1 MELK SYNE2 DNAH5 ARAP2 SYNE1 IL1RL1 TOP2A	2.58e-06	188	204	8	186fe1ea328c942910190a4240262c0d8642ea3b
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLCO1C1 ARHGAP31 UGT8 FGFR3 MYRF PREX1 PADI2 PSD4	2.79e-06	190	204	8	2de8e4cfeee350a9a76af749d6ce58d948c129b8
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLCO1C1 ARHGAP31 UGT8 FGFR3 MYRF PREX1 PADI2 PSD4	2.90e-06	191	204	8	f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 RERG DOCK11 SATB1 GRIK3 LHX6 SLC9A2 PIEZO2	3.13e-06	193	204	8	c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 DOCK11 DAB1 SATB1 GRIK3 LHX6 SLC9A2 PIEZO2	3.26e-06	194	204	8	1bcb3fafd498614f7bac2b1c9b7de56e39110f65
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO1A DAB1 MEP1A UGT8 FGFR3 RNF128 VIL1 TUBAL3	3.26e-06	194	204	8	fcbf9c4f3801ab1a34fcd62c752fabc97fc7bde1
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD2 RERG PDE4B DOCK11 GRIK3 LHX6 SLC9A2 PIEZO2	4.08e-06	200	204	8	a9cdddc4e985dae59521e557479c24fcc2ac727d
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	RERG CRIM1 PDGFA DOCK11 MARK1 SYNE1 PRKG1 CSMD1	4.08e-06	200	204	8	c06426f877919bdd267ea2fd7e7973c6619832ae
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD2 RERG PDE4B DOCK11 GRIK3 LHX6 SLC9A2 PIEZO2	4.08e-06	200	204	8	9719fabddc34051949468a7520289e3c750de4f8
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD2 RERG PDE4B DOCK11 GRIK3 LHX6 SLC9A2 PIEZO2	4.08e-06	200	204	8	33b9199e0dfc267e2cea20b82d1c167f8adcc635
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	MYH9 SYNE2 DIAPH1 ARAP2 SYNE1 FUT11 MYOM2 PSD4	4.08e-06	200	204	8	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GAD2 RERG DACT1 SATB1 GRIK3 LHX6 GLCE	5.29e-06	147	204	7	50e86860a94be103092c40e39a172eac92372f0d
ToppCell	E18.5-samps-Mesenchymal-Pericyte-pericyte_C\|E18.5-samps / Age Group, Lineage, Cell class and subclass	CRIM1 DOCK11 MARK1 DACT1 HJV TIMP4 DHRS7C	6.31e-06	151	204	7	3f2abaa42876ce7a71d934ff16abe0cab0991a05
ToppCell	facs-SCAT-Fat-18m-Epithelial\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1A MEP1A UGT8 HSD17B2 VIL1 SLC9A2 TUBAL3	1.00e-05	162	204	7	341fa357ad7bdbef30864e8062f161e60185ffc9
ToppCell	facs-SCAT-Fat-18m-Epithelial-nan\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1A MEP1A UGT8 HSD17B2 VIL1 SLC9A2 TUBAL3	1.00e-05	162	204	7	7fa93efa2039d68a4e8214fa143bcd3368349a2d
ToppCell	facs-SCAT-Fat-18m-Epithelial-epithelial_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1A MEP1A UGT8 HSD17B2 VIL1 SLC9A2 TUBAL3	1.00e-05	162	204	7	7215f6eb2b65dea455e2eec722a9c38e6958b120
ToppCell	LA-16._Neuronal\|World / Chamber and Cluster_Paper	DLC1 LRRTM4 UGT8 ARAP2 GRIK3 CDH15 EPB41L2	1.27e-05	168	204	7	2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e
ToppCell	LA-16._Neuronal\|LA / Chamber and Cluster_Paper	DLC1 ARHGAP31 LRRTM4 UGT8 ARAP2 GRIK3 CDH15	1.27e-05	168	204	7	c55bbfbde8bb954f1cb9af82007bdd1f8070fee3
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	RERG MARK1 DLC1 SLCO1C1 LRRTM4 PRKG1 EPB41L2	1.42e-05	171	204	7	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	ASK454-Epithelial-Transformed_epithelium\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	FEM1C PDXDC2P APPBP2 ZSWIM5 MYO15A PADI2 CDH15	1.48e-05	172	204	7	3986f0f098ef5e096c8d9ee3d335b8404083701f
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFA TBC1D16 DACT1 ITPKC PRKAR1B PDE5A PRKG1	1.53e-05	173	204	7	36c8338463ee4cc432f568728d55989360f9a68d
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFA TBC1D16 DACT1 ITPKC PRKAR1B PDE5A PRKG1	1.53e-05	173	204	7	3059325901b1e5e12a1a91183f14267288b2f600
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH10 CRIM1 PHYHIP SYNE2 TACR2 MYRF LRRC52	1.53e-05	173	204	7	30d67738633493d47f06ae452424382f069b6c0a
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RERG CDKL3 ACAD11 SPIN2A HSD17B2 CASP2 PRKG1	1.65e-05	175	204	7	aa168aeb9ad71aa6c0c28a0657c9eb92a0b28183
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RERG MARK1 DLC1 SLCO1C1 LRRTM4 PRKG1 EPB41L2	1.84e-05	178	204	7	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RERG CRIM1 MARK1 PDE5A MYOM2 PRKG1 CSMD1	1.84e-05	178	204	7	066dbc4cc2083c549d98122ed44707127f34d582
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MFSD6 FNDC7 GRK3 UAP1L1 BMP2K VPS26B POLR3A	1.98e-05	180	204	7	be10fe5bf7c3a671c42704ce7dd8226ab6896794
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MFSD6 FNDC7 GRK3 UAP1L1 BMP2K VPS26B POLR3A	1.98e-05	180	204	7	3b747a517ce75ef2ff09011c037dad7b01ed3e03
ToppCell	RA-16._Neuronal\|RA / Chamber and Cluster_Paper	PDGFA DLC1 LRRTM4 ARAP2 GRIA1 GRIK3 EPB41L2	1.98e-05	180	204	7	5842febfdabac61ce970254fb0ef17a628f1b8c0
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RERG MYH10 C2CD6 GRIA1 PIEZO2 PDE5A PRKG1	2.05e-05	181	204	7	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Lymphocytic-T_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRIM36 CASP2 LHX6 ATP10A CXCR6 IL1RL1 PSD4	2.05e-05	181	204	7	8a8061725e718c89a4c751a415120c5312acc757
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	RERG MYH10 CRIM1 DLC1 ATP10A PDE5A PRKG1	2.20e-05	183	204	7	818fd886e0188091310825f9145fa53328f2c979
ToppCell	COVID-19_Mild-gd_T\|COVID-19_Mild / Disease condition and Cell class	MYH9 SYNE2 DIAPH1 ARAP2 SYNE1 ZBTB1 MYOM2	2.20e-05	183	204	7	f593a89b0aa8fffdfa403769916facfd30358521
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL22A1 DNAH5 GRIK3 PIEZO2 MYOM2 CSMD1 MYO15A	2.28e-05	184	204	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RERG CRIM1 PDGFA DACT1 ASB15 PDE5A PRKG1	2.28e-05	184	204	7	4cb5f299dd7413e0be1ad7af817ee614b23a18ae
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL22A1 DNAH5 GRIK3 PIEZO2 MYOM2 CSMD1 MYO15A	2.28e-05	184	204	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL22A1 DNAH5 GRIK3 PIEZO2 MYOM2 CSMD1 MYO15A	2.28e-05	184	204	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RERG CRIM1 PDGFA DACT1 ASB15 PDE5A PRKG1	2.28e-05	184	204	7	39bb0eb55bdc2cea46e41c7f21d8c5883f14e6bd
ToppCell	droplet-Bladder-BLADDER-1m-Hematologic-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK11 MELK SPIN2A PREX1 RGS1 CXCR6 TOP2A	2.36e-05	185	204	7	969248b63d4ce335f223528de756bcddffadbd77
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GAD2 RERG DOCK11 DPYSL5 RNF128 LHX6 PDE5A	2.36e-05	185	204	7	739260f8abebaf10a5cc49d91726278579e26170
ToppCell	facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH9 JARID2 SATB1 ARAP2 ADNP ANKRD17 SLC45A2	2.36e-05	185	204	7	a2cae8c657e4f4d121476798e424876f7e247973
ToppCell	P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RERG CRIM1 PDGFA GRK3 PRKAR1B PDE5A PRKG1	2.36e-05	185	204	7	b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e
ToppCell	facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH9 JARID2 SATB1 ARAP2 ADNP ANKRD17 SLC45A2	2.36e-05	185	204	7	d50406a9a5b8d75110ba5985741aa2293950c543
ToppCell	facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PHYHIP RNF128 FHIP1A HJV SLC9A2 DHRS7C MYOM2	2.44e-05	186	204	7	337f768cc43db2db96ba6495b076006b1a5b0331
ToppCell	facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PHYHIP RNF128 FHIP1A HJV SLC9A2 DHRS7C MYOM2	2.44e-05	186	204	7	e378c82ef6d6cb24751515aa499a01372b3e7ccf
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 DOCK11 DAB1 GRIK3 LHX6 SLC9A2 PIEZO2	2.53e-05	187	204	7	85f1678338a47d91e296f0620d4887f057eb7e70
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	UGT8 FGFR3 MYRF PREX1 PIEZO2 DPF3 PADI2	2.53e-05	187	204	7	97e520705491c8f52a32025311a9fa7b9176979a
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLCO1C1 ARHGAP31 UGT8 FGFR3 MYRF PREX1 PADI2	2.62e-05	188	204	7	505b6b4277d7dea87aee27191d0acca67928b8e6
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	SMG1 INO80D DDX3X SYNE2 ARAP2 PARP14 JMJD1C	2.62e-05	188	204	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RERG CRIM1 MARK1 SLCO1C1 LRRTM4 PRKG1 EPB41L2	2.62e-05	188	204	7	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CRIM1 DACT1 DLC1 PRKAR1B PDE5A PRKG1 EPB41L2	2.71e-05	189	204	7	26cfe5b7e7f477f225f4e9f25f983f432f01e183
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	RERG MYH9 MYH10 CRIM1 DAB1 ATP10A PRKG1	2.71e-05	189	204	7	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLCO1C1 ARHGAP31 UGT8 FGFR3 MYRF PREX1 PADI2	2.71e-05	189	204	7	37ecbd73408d462b47d7e5611f203143e08a2689
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLCO1C1 UGT8 FGFR3 MYRF PREX1 PIEZO2 PADI2	2.80e-05	190	204	7	ae97df1b06bcd46c05759b53c35dc8fea97f4ac1
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CRIM1 DACT1 DLC1 PRKAR1B PDE5A PRKG1 EPB41L2	2.80e-05	190	204	7	2ab604d35456beba71c25511e0f819000e6642d2
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RERG CRIM1 MARK1 DLC1 SLCO1C1 LRRTM4 PRKG1	2.80e-05	190	204	7	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RERG CRIM1 MARK1 DLC1 SLCO1C1 LRRTM4 PRKG1	2.80e-05	190	204	7	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TBC1D24 WDR62 GEMIN5 ZNF865 CSMD1 MYO15A	2.89e-05	129	204	6	cbeeaa554da971ba2e4c4b82c85a1d070a45abb8
ToppCell	Mesenchymal-vascular_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	RERG MYH10 CRIM1 MARK1 MYOM2 PRKG1 CSMD1	2.89e-05	191	204	7	fd89fbc62aa1c73e0f659991e3bd726a0c97bd68
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLCO1C1 ARHGAP31 UGT8 FGFR3 MYRF PREX1 PADI2	2.89e-05	191	204	7	a90c8ab2077e52bbc998457c85a1b9867f9c8c93
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 DOCK11 SATB1 GRIK3 LHX6 SLC9A2 PIEZO2	2.99e-05	192	204	7	dc40ef2341e5d6a6d479f140e023fe1bf687928d
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 DOCK11 SATB1 GRIK3 LHX6 SLC9A2 PIEZO2	3.09e-05	193	204	7	d1445b8bf2bab36e1a326ddb2a528151db016c7d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 DOCK11 SATB1 GRIK3 LHX6 SLC9A2 PIEZO2	3.09e-05	193	204	7	2189da4b727e25e62669d7b9257f06493be21a27
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 DOCK11 SATB1 GRIK3 LHX6 SLC9A2 PIEZO2	3.09e-05	193	204	7	3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b
ToppCell	droplet-Tongue-nan-3m-Epithelial-suprabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLC1 SYNE2 WDR62 ARAP2 BICD2 S100A7A EPB41L2	3.09e-05	193	204	7	a7002acf3be76b2cc6fc9364176f6b0d3bd27d9c
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RERG MYH10 DLC1 GRIA1 PIEZO2 PDE5A PRKG1	3.09e-05	193	204	7	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RERG MYH10 DLC1 GRIA1 PIEZO2 PDE5A PRKG1	3.09e-05	193	204	7	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 DOCK11 DAB1 SATB1 GRIK3 LHX6 SLC9A2	3.09e-05	193	204	7	e74fdc8718fe0933e1f4dd3fe37e2134983b99b6
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 DOCK11 DAB1 SATB1 GRIK3 LHX6 SLC9A2	3.09e-05	193	204	7	658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 RERG DOCK11 GRIK3 LHX6 SLC9A2 PIEZO2	3.20e-05	194	204	7	83863da11dfbe59b2d0a2c08db40b537c150588c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 DLC1 HSD17B2 PIEZO2 PDE5A PRKG1 EPB41L2	3.20e-05	194	204	7	90efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 DLC1 HSD17B2 PIEZO2 PDE5A PRKG1 EPB41L2	3.20e-05	194	204	7	df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RERG DLC1 GRK3 SLCO1C1 HSD17B2 PIEZO2 EPB41L2	3.30e-05	195	204	7	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RERG DLC1 GRK3 SLCO1C1 HSD17B2 PIEZO2 EPB41L2	3.30e-05	195	204	7	4f70157d42a16ff0259bc24a62803c4df4285c44
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	RERG MYH10 CRIM1 GRIA1 PIEZO2 PDE5A PRKG1	3.30e-05	195	204	7	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IL13RA2 DLC1 ARHGAP31 PREX1 SYNE1 PIEZO2 CCM2L	3.30e-05	195	204	7	23ced69fd904f1d4114b1a7f99f4b5f65ea8824b
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RERG MYH10 DLC1 SYNE1 GRIA1 PRKG1 EPB41L2	3.52e-05	197	204	7	0dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell	facs-Tongue-nan-3m-Epithelial\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 MYH9 DDX3X HNRNPK GLG1 ARAP2 TNKS2	3.64e-05	198	204	7	2f03f8897dd7cce6d8296638e14e11ec16bcf624
ToppCell	metastatic_Brain-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	MYH9 PDGFA DLC1 SYNE2 PDE5A PRKG1 EPB41L1	3.64e-05	198	204	7	86a4c8e859ce11a95875f8844963baeb1ba898ec
ToppCell	facs-Tongue-nan-3m\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 MYH9 DDX3X HNRNPK GLG1 ARAP2 TNKS2	3.64e-05	198	204	7	f2a4057f038ef7225a5b98a7ab068c30dff4eadd
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	CRIM1 INSR SYNE2 DNAH5 ADNP BAZ1A BRD4	3.76e-05	199	204	7	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	facs-Tongue-nan-3m-Epithelial-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 MYH9 DDB1 DDX3X HNRNPK GLG1 TNKS2	3.76e-05	199	204	7	8d50e1ee58710d896c0204937331d9f4dcd38de0
ToppCell	COVID-19-lung\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE4B DOCK11 GRK3 ARAP2 PARP14 ATP10A BAZ1A	3.76e-05	199	204	7	155b03b859157013e9142e9248551369127d9204
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	RERG MYH10 GRIA1 PIEZO2 PDE5A PRKG1 EPB41L2	3.88e-05	200	204	7	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 DDX3X SYNE2 ARAP2 PARP14 JMJD1C SETD2	3.88e-05	200	204	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	RERG MYH10 GRIA1 PIEZO2 PDE5A PRKG1 EPB41L2	3.88e-05	200	204	7	a510deaada669e690329183e18df02870bd204b3
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte\|LPS_only / Treatment groups by lineage, cell group, cell type	RERG CRIM1 PDGFA DACT1 SYNE1 PDE5A CSMD1	3.88e-05	200	204	7	8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD2 DOCK11 SATB1 GRIK3 LHX6 SLC9A2 PIEZO2	3.88e-05	200	204	7	cb1f4b0d66da5b0466ff17b29e7034d451d93e4f
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	RERG CRIM1 DOCK11 GRK3 PDE5A TNFAIP6 EPB41L2	3.88e-05	200	204	7	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD2 DOCK11 SATB1 GRIK3 LHX6 SLC9A2 PIEZO2	3.88e-05	200	204	7	6a44439e4a7ce3627271375b04cfcfb9467218f4
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RERG MYH10 GRIA1 PIEZO2 PDE5A PRKG1 TNFAIP6	3.88e-05	200	204	7	8c62f05c6042f24287a73fbdf80ff4a56f7ff403
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PDGFA DOCK11 MARK1 DACT1 SYNE1 PRKG1 CSMD1	3.88e-05	200	204	7	a3a1e35934d676c39f917652e50c502cb2f613c1
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	RERG CRIM1 PDGFA DOCK11 DACT1 SLCO1C1 PDE5A	3.88e-05	200	204	7	cf883ba5dbe6350b93142d625a52b25ff2a8bb63
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	RERG PDGFA DOCK11 DACT1 SYNE1 PDE5A PRKG1	3.88e-05	200	204	7	b22cae282591d8dead9869c2adbb9632615f50f7
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-STK32A\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD2 DOCK11 SATB1 GRIK3 LHX6 SLC9A2 PIEZO2	3.88e-05	200	204	7	8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	MYH9 DDX3X SYNE2 DIAPH1 PARP14 ZBTB1 SETD2	3.88e-05	200	204	7	7dec470c379cd89f05a0f37c8628b21f136e52f0
Drug	Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A	MAST2 INO80D DLC1 GRK2 BMP2K APAF1 LMTK2 ZBTB1 VPS9D1 DPF3 PDE5A	1.59e-06	197	202	11	6061_DN
Drug	Ursolic acid [77-52-1]; Up 200; 8.8uM; PC3; HT_HG-U133A	GRK2 GRK3 SATB1 GLG1 MYRF UAP1L1 CASP2 ATP10A ITPKC TNKS2	9.23e-06	193	202	10	2067_UP
Drug	NSC339663	MYH9 MYH10 MYO1A INSR SYNE2 IMMT VIL1 SYNE1 MTOR MYO15A TUBAL3	1.54e-05	250	202	11	CID000003892
Drug	palladium	PDC INSR DNAH5 SYNE1 PPP4C PADI2	3.14e-05	68	202	6	CID000023938
Drug	1-hydroxypyrazole	SYNE1 GRIA1 GRIA4	3.73e-05	8	202	3	CID003016733
Drug	1-hydroxyimidazole	SYNE1 GRIA1 GRIA4	3.73e-05	8	202	3	CID003614351
Drug	17-AAG; Up 200; 1uM; PC3; HT_HG-U133A	GAD2 PDE4B DDX3X ADD2 PURG VPS9D1 PRKAR1B SLC45A2 RBM34	5.04e-05	189	202	9	4430_UP
Drug	AC1L1G3W	GAD2 PDC PDE4B INSR AKR1B1 APAF1 SETD2 TIMP4 PDE5A PRKG1	5.38e-05	237	202	10	CID000003514
Drug	potassium amyl xanthate	AKR1B10 AKR1B1 HJV	5.56e-05	9	202	3	CID000017635
Drug	Ly294486	GRIA1 GRIA4 GRIK3	5.56e-05	9	202	3	CID005311255
Drug	LY339434	GRIA1 GRIA4 GRIK3	5.56e-05	9	202	3	CID006324635
Drug	Calycanthine [595-05-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A	GAD2 MAST2 INO80D DLC1 SLCO1C1 SYNE1 ATP10A NECAB3 MYOM2	5.93e-05	193	202	9	2764_UP
Drug	milrinone	PDE4B PLCXD1 MEP1A GRK2 GRK3 SYNE1 PDE5A PRKG1	5.99e-05	150	202	8	CID000004197
Drug	Glycocholic acid [475-31-0]; Down 200; 8.6uM; HL60; HT_HG-U133A	CDKL3 GRK3 GLG1 UAP1L1 CENPT BMP2K CASP2 ATP10A PRKAR1B	6.42e-05	195	202	9	2454_DN
Drug	ODAP	NDUFV1 IMMT GRIA1 GRIA4 GRIK3	6.57e-05	48	202	5	CID000002360
Drug	Trimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; MCF7; HT_HG-U133A	GRK3 SATB1 APAF1 VPS9D1 CXCR6 DPF3 PRKAR1B TNFAIP6 PSD4	6.67e-05	196	202	9	2876_UP
Drug	clozapine; Up 200; 10uM; PC3; HT_HG-U133A	GAD2 DDX3X GRK3 LMTK2 GRIA4 RGS1 EFHC2 LIPE PRKG1	6.67e-05	196	202	9	4453_UP
Drug	Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A	DDX3X DLC1 UAP1L1 WDR62 SLC9A2 BRD4 PRKAR1B TNKS2 EPB41L2	6.67e-05	196	202	9	5540_DN
Drug	0175029-0000 [211245-78-2]; Up 200; 1uM; PC3; HT_HG-U133A	PHYHIP ZZEF1 GRK2 GRK3 ATP10A PDE5A IL1RL1 PRKG1 MYO15A	6.94e-05	197	202	9	3694_UP
Drug	Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; HL60; HT_HG-U133A	PDE4B PDGFA CDKL3 INO80D SLCO1C1 WDR62 ARAP2 APAF1 CASP2	7.22e-05	198	202	9	2188_DN
Drug	Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; PC3; HT_HG-U133A	MAST2 GRK3 APAF1 CASP2 GRIA4 TDRD1 LIPE MYO15A PSD4	7.22e-05	198	202	9	3695_UP
Drug	Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; HL60; HG-U133A	GRK2 METAP2 APPBP2 APAF1 CASP2 JMJD1C SETD2 EPB41L2 PSD4	7.50e-05	199	202	9	1383_UP
Drug	lithium indium	SPIN2A SPIN2B	7.83e-05	2	202	2	CID011116062
Drug	scandium phosphate	SPIN2A SPIN2B	7.83e-05	2	202	2	CID006365269
Drug	4-oxoretinaldehyde	AKR1B10 AKR1B1	7.83e-05	2	202	2	ctd:C099660
Drug	3-(2-bromoethyl)indole	SYNE1 PPP4C	7.83e-05	2	202	2	CID000076924
Drug	propioin	AKR1B10 AKR1B1	7.83e-05	2	202	2	ctd:C523189
Drug	dehydroretinal	AKR1B10 AKR1B1	7.83e-05	2	202	2	ctd:C017184
Drug	Pentanones	AKR1B10 AKR1B1	7.83e-05	2	202	2	ctd:D010422
Drug	4-hydroxyretinal	AKR1B10 AKR1B1	7.83e-05	2	202	2	ctd:C057180
Drug	antiarol	AKR1B1 SYNE1	7.83e-05	2	202	2	CID000069505
Drug	p-phenyl-phenacylbromide	SYNE1 PPP4C	7.83e-05	2	202	2	CID000067282
Drug	rubidium nitrate	SPIN2A SPIN2B	7.83e-05	2	202	2	CID000025731
Disease	sensorineural hearing loss (is_implicated_in)	MYH9 MYO1A DIAPH1 TECTA MYO15A	2.63e-06	33	198	5	DOID:10003 (is_implicated_in)
Disease	red blood cell density measurement	PDXDC1 RERG TRIT1 MAST2 UGT8 CC2D2A MYRF PREX1 VIL1 USP49 BMP2K JMJD1C BAZ1A BRD4 PRKAR1B TAF5L FBXL20 MYO15A PSD4	8.35e-06	880	198	19	EFO_0007978
Disease	Intellectual Disability	TRRAP DDX3X HNRNPK SACS DIAPH1 WDR62 SYNE1 CASP2 GRIA1 SETD2 MTOR BRD4 EPB41L1	1.14e-05	447	198	13	C3714756
Disease	Sarcomatoid Renal Cell Carcinoma	PDXDC1 SYNE2 APAF1 CASP2 ASB15 SETD2 MTOR	2.62e-05	128	198	7	C1266043
Disease	Chromophobe Renal Cell Carcinoma	PDXDC1 SYNE2 APAF1 CASP2 ASB15 SETD2 MTOR	2.62e-05	128	198	7	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	PDXDC1 SYNE2 APAF1 CASP2 ASB15 SETD2 MTOR	2.62e-05	128	198	7	C1266044
Disease	Papillary Renal Cell Carcinoma	PDXDC1 SYNE2 APAF1 CASP2 ASB15 SETD2 MTOR	2.62e-05	128	198	7	C1306837
Disease	Renal Cell Carcinoma	PDXDC1 SYNE2 APAF1 CASP2 ASB15 SETD2 MTOR	2.62e-05	128	198	7	C0007134
Disease	Ovarian Mucinous Adenocarcinoma	MAST2 TRRAP MELK MTOR	5.37e-05	31	198	4	C1335167
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	PDXDC1 SYNE2 APAF1 CASP2 ASB15 SETD2 MTOR	6.63e-05	148	198	7	C0279702
Disease	reticulocyte count	GAD2 MYH9 INSR MAST2 INO80D SYNE2 VPS13A SPIN2A AKR1B1 MYRF METAP2 USP49 BMP2K GEMIN5 JMJD1C BAZ1A DPF3 FBXL20 PCID2	8.59e-05	1045	198	19	EFO_0007986
Disease	Drug habituation	INSR DDX1 SYNE1 GRIA4 SLC45A2 CSMD1	1.30e-04	115	198	6	C0013170
Disease	Drug abuse	INSR DDX1 SYNE1 GRIA4 SLC45A2 CSMD1	1.30e-04	115	198	6	C0013146
Disease	Prescription Drug Abuse	INSR DDX1 SYNE1 GRIA4 SLC45A2 CSMD1	1.30e-04	115	198	6	C4316881
Disease	Substance-Related Disorders	INSR DDX1 SYNE1 GRIA4 SLC45A2 CSMD1	1.30e-04	115	198	6	C0236969
Disease	Drug Use Disorders	INSR DDX1 SYNE1 GRIA4 SLC45A2 CSMD1	1.30e-04	115	198	6	C0013222
Disease	Drug Dependence	INSR DDX1 SYNE1 GRIA4 SLC45A2 CSMD1	1.30e-04	115	198	6	C1510472
Disease	Substance Dependence	INSR DDX1 SYNE1 GRIA4 SLC45A2 CSMD1	1.30e-04	115	198	6	C0038580
Disease	Substance Use Disorders	INSR DDX1 SYNE1 GRIA4 SLC45A2 CSMD1	1.30e-04	115	198	6	C0038586
Disease	Organic Mental Disorders, Substance-Induced	INSR DDX1 SYNE1 GRIA4 SLC45A2 CSMD1	1.30e-04	115	198	6	C0029231
Disease	Substance abuse problem	INSR DDX1 SYNE1 GRIA4 SLC45A2 CSMD1	1.36e-04	116	198	6	C0740858
Disease	central nervous system disease (implicated_via_orthology)	GEMIN5 GRIA1 GRIA4	1.56e-04	16	198	3	DOID:331 (implicated_via_orthology)
Disease	insomnia measurement	PDXDC1 PDE4B MFSD6 DAB1 LRRTM4 METAP2 PURG FBXL17 GRIA1 GRIK3 PHF14	2.17e-04	443	198	11	EFO_0007876
Disease	aldose reductase measurement	AKR1B10 AKR1B1	2.66e-04	4	198	2	EFO_0801364
Disease	Autosomal dominant Emery-Dreifuss muscular dystrophy	SYNE2 SYNE1	2.66e-04	4	198	2	cv:CN293514
Disease	mean reticulocyte volume	MYH9 CRIM1 TRRAP TBC1D24 TBC1D16 VPS13A CC2D2A PREX1 USP49 JMJD1C MTOR BRD4 FBXL20 CDH15 EPB41L2	3.48e-04	799	198	15	EFO_0010701
Disease	docosahexaenoic acid to total fatty acids percentage	PDXDC1 MYRF JMJD1C	3.62e-04	21	198	3	EFO_0022262
Disease	Autistic Disorder	PDE4B MARK1 DAB1 TRRAP GRIA1 ADNP ATP10A JMJD1C	4.03e-04	261	198	8	C0004352
Disease	blood pressure	PREX1 SYNE1 RGS1	4.17e-04	22	198	3	EFO_0004325
Disease	clostridium difficile infection	INSR NDUFV1 TRIM36 CSMD1 RBM43 PCID2	4.38e-04	144	198	6	EFO_0009130
Disease	fibroblast growth factor receptor 3 measurement	FGFR3 TNKS2	4.42e-04	5	198	2	EFO_0020390
Disease	Autosomal Recessive Emery-Dreifuss Muscular Dystrophy	SYNE2 SYNE1	4.42e-04	5	198	2	C1450051
Disease	Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)	SYNE2 SYNE1	4.42e-04	5	198	2	C0410190
Disease	quality of life during menstruation measurement, Arthralgia	GAD2 DOP1B	4.42e-04	5	198	2	EFO_0009366, HP_0002829
Disease	hearing impairment	MYO1A DIAPH1 FGFR3 TECTA MYO15A	5.30e-04	98	198	5	C1384666
Disease	alpha-linolenic acid measurement	PDXDC1 MYRF CSMD1	6.14e-04	25	198	3	EFO_0007759
Disease	Emery-Dreifuss muscular dystrophy	SYNE2 SYNE1	6.60e-04	6	198	2	cv:C0410189
Disease	Muscular Dystrophy, Emery-Dreifuss	SYNE2 SYNE1	6.60e-04	6	198	2	C0410189
Disease	tumor necrosis factor-inducible gene 6 protein measurement	TNFAIP6 RBM43	6.60e-04	6	198	2	EFO_0008311
Disease	cutaneous melanoma, hair color	SYNE2 ATP10A SLC45A2 CDH15	8.09e-04	62	198	4	EFO_0000389, EFO_0003924
Disease	X-Linked Emery-Dreifuss Muscular Dystrophy	SYNE2 SYNE1	9.20e-04	7	198	2	C0751337
Disease	Autosomal dominant nonsyndromic hearing loss	MYH9 DIAPH1 TECTA	9.56e-04	29	198	3	cv:C5779548
Disease	Malignant neoplasm of breast	KDM3A MYH9 PDGFA FEM1C DDX3X HNRNPK SYNE2 PURG ZSWIM5 SYNE1 GRIK3 TECTA SETD2 SLC9A2 LIPE MTOR TOP2A	9.75e-04	1074	198	17	C0006142
Disease	pneumonia, COVID-19	DAB1 MELK METAP2 SACM1L CSMD1	1.01e-03	113	198	5	EFO_0003106, MONDO_0100096
Disease	sleep apnea measurement	INO80D DLC1 ASB15 SLC9A2 SLC45A2	1.14e-03	116	198	5	EFO_0007817
Disease	gestational diabetes (is_implicated_in)	GAD2 INSR	1.22e-03	8	198	2	DOID:11714 (is_implicated_in)
Disease	cerebellar ataxia (implicated_via_orthology)	VPS13A GEMIN5	1.22e-03	8	198	2	DOID:0050753 (implicated_via_orthology)
Disease	Dickkopf-related protein 4 measurement	JMJD1C PRKG1	1.22e-03	8	198	2	EFO_0008110
Disease	Large cell carcinoma of lung	TRRAP LMTK2 MTOR	1.28e-03	32	198	3	C0345958
Disease	metabolite measurement, diet measurement	PDXDC1 PDXDC2P MYRF JMJD1C	1.35e-03	71	198	4	EFO_0004725, EFO_0008111
Disease	colorectal cancer (is_implicated_in)	DDX3X DLC1 FGFR3 ITPKC SETD2	1.37e-03	121	198	5	DOID:9256 (is_implicated_in)
Disease	idiopathic pulmonary fibrosis (is_implicated_in)	SETD2 BRD4	1.56e-03	9	198	2	DOID:0050156 (is_implicated_in)
Disease	level of Phosphatidylcholine (O-18:1_20:3) in blood serum	PDXDC1 MYRF	1.56e-03	9	198	2	OBA_2045130
Disease	level of Sphingomyelin (d36:1) in blood serum	ANKRD17 KCNH5	1.56e-03	9	198	2	OBA_2045178
Disease	white matter growth measurement	AKR1B10 AKR1B1	1.56e-03	9	198	2	EFO_0009335
Disease	1-stearoyl-2-arachidonoyl-GPC (18:0/20:4) measurement	PDXDC1 MYRF	1.56e-03	9	198	2	EFO_0800271
Disease	Nonsyndromic genetic hearing loss	MYH9 DIAPH1 TECTA MYO15A	1.73e-03	76	198	4	cv:C5680182
Disease	postburn hypertrophic scarring severity measurement	ARAP2 CSMD1	1.95e-03	10	198	2	EFO_0007747
Disease	reticulocyte measurement	MYH9 INSR SYNE2 VPS13A SPIN2A AKR1B1 METAP2 PREX1 VIL1 BMP2K JMJD1C BAZ1A BRD4 PDE5A FBXL20 PCID2	2.07e-03	1053	198	16	EFO_0010700
Disease	alcohol use disorder (implicated_via_orthology)	KDM3A GAD2 JMJD1C DPF3 CDC5L PSD4	2.10e-03	195	198	6	DOID:1574 (implicated_via_orthology)
Disease	cataract (implicated_via_orthology)	CRIM1 AKR1B1 SLC45A2	2.11e-03	38	198	3	DOID:83 (implicated_via_orthology)
Disease	progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma	PDE4B UGT8 ARAP2	2.28e-03	39	198	3	EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354
Disease	degree of unsaturation measurement	PDXDC1 MYRF JMJD1C	2.28e-03	39	198	3	EFO_0022261
Disease	congestive heart failure (is_marker_for)	CDK9 GRK2 GRK3 MTOR	2.29e-03	82	198	4	DOID:6000 (is_marker_for)
Disease	interleukin 1 receptor-like 1 measurement	SLC9A2 IL1RL1	2.37e-03	11	198	2	EFO_0008168
Disease	docosahexaenoic acid measurement, fatty acid measurement	PDXDC1 MYRF JMJD1C	2.45e-03	40	198	3	EFO_0005110, EFO_0007761
Disease	cervical cancer	PDE4B COL22A1 JARID2	2.45e-03	40	198	3	MONDO_0002974
Disease	Emery-Dreifuss muscular dystrophy (implicated_via_orthology)	SYNE2 SYNE1	2.83e-03	12	198	2	DOID:11726 (implicated_via_orthology)
Disease	level of Phosphatidylcholine (O-16:0_20:3) in blood serum	PDXDC1 MYRF	2.83e-03	12	198	2	OBA_2045115
Disease	cholesteryl ester 20:2 measurement	MYRF UVRAG	2.83e-03	12	198	2	EFO_0021440
Disease	dickkopf‐related protein 1 measurement	JMJD1C PRKG1	2.83e-03	12	198	2	EFO_0010620
Disease	neurodegenerative disease (implicated_via_orthology)	MARK1 TBC1D24 GRIA1 GRIA4 GRIK3	3.02e-03	145	198	5	DOID:1289 (implicated_via_orthology)
Disease	creatinine measurement	RERG FRMD7 DPYSL5 MAST2 DDX1 DLC1 RNF128 AKR1B1 VIL1 FBXL17 SLC9A2 DPF3 FBXL20 MINDY1 PSD4	3.06e-03	995	198	15	EFO_0004518
Disease	childhood aggressive behaviour measurement	DLC1 LRRTM4 HECTD1 GRIA1	3.08e-03	89	198	4	EFO_0007663
Disease	eye color	FBXL17 SLC45A2 CSMD1 EFCAB7	3.21e-03	90	198	4	EFO_0003949
Disease	high grade glioma (implicated_via_orthology)	INSR FGFR3 WDR62	3.22e-03	44	198	3	DOID:3070 (implicated_via_orthology)
Disease	Thyroid carcinoma	PDGFA MTOR BRD4	3.22e-03	44	198	3	C0549473
Disease	dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement	PDXDC1 MYRF	3.33e-03	13	198	2	EFO_0800547
Disease	level of Sphingomyelin (d34:2) in blood serum	MYRF ANKRD17	3.33e-03	13	198	2	OBA_2045174
Disease	nevus count, cutaneous melanoma	JARID2 SYNE2 SLC45A2 CDH15	3.34e-03	91	198	4	EFO_0000389, EFO_0004632
Disease	Gastric Adenocarcinoma	MARK1 INSR TRRAP	3.43e-03	45	198	3	C0278701
Disease	hematocrit	RERG MYH9 FRMD7 INSR MAST2 ACAD11 UGT8 MYRF DPF3 PRKAR1B ANKRD17 CDC5L FBXL20 PADI2 PSD4	3.55e-03	1011	198	15	EFO_0004348
Disease	Malformations of Cortical Development	WDR62 MTOR	3.87e-03	14	198	2	C1955869
Disease	Cortical Dysplasia	WDR62 MTOR	3.87e-03	14	198	2	C0431380
Disease	diabetic neuropathy (implicated_via_orthology)	INSR AKR1B1	3.87e-03	14	198	2	DOID:9743 (implicated_via_orthology)
Disease	Adenocarcinoma of large intestine	TRRAP DLC1 GRK2 FGFR3	4.04e-03	96	198	4	C1319315
Disease	sunburn	PDE4B USP49 WDPCP SLC45A2	4.04e-03	96	198	4	EFO_0003958
Disease	brain measurement, neuroimaging measurement	PDXDC1 DPYSL5 DAB1 DACT1 ACAD11 FGFR3 METAP2 TANGO6 SACM1L EMC2	4.20e-03	550	198	10	EFO_0004346, EFO_0004464
Disease	body surface area	PDXDC1 PDE4B CRIM1 INSR DLC1 SLCO1C1 GRIA1 MTOR PRKG1 EPB41L2 PSD4	4.30e-03	643	198	11	EFO_0022196
Disease	glycerophospholipid measurement	SYNE2 UGT8 MYRF	4.37e-03	49	198	3	EFO_0007630
Disease	Meckel-Gruber syndrome	CC2D2A WDPCP	4.44e-03	15	198	2	C0265215
Disease	Neoplasm of uncertain or unknown behavior of bladder	FGFR3 MTOR	4.44e-03	15	198	2	C0496930
Disease	interleukin 18 receptor 1 measurement	SLC9A2 IL1RL1	4.44e-03	15	198	2	EFO_0008178
Disease	Benign neoplasm of bladder	FGFR3 MTOR	4.44e-03	15	198	2	C0154017
Disease	Carcinoma in situ of bladder	FGFR3 MTOR	4.44e-03	15	198	2	C0154091
Disease	impotence (implicated_via_orthology)	GRK2 PDE5A	4.44e-03	15	198	2	DOID:1875 (implicated_via_orthology)
Disease	hepatic encephalopathy (biomarker_via_orthology)	INSR GRIA1	4.44e-03	15	198	2	DOID:13413 (biomarker_via_orthology)
Disease	omega-6:omega-3 polyunsaturated fatty acid ratio	PDXDC1 MYRF JMJD1C	4.63e-03	50	198	3	EFO_0010732
Disease	neurotic disorder	FBXL17 GRIK3 CSMD1 AGBL2	4.84e-03	101	198	4	EFO_0004257
Disease	interferon gamma measurement	DAB1 JMJD1C IBTK	4.89e-03	51	198	3	EFO_0008165

Protein segments in the cluster

Peptide	Gene	Start	Entry
PGEFYCHVLKEDALK	TDRD1	726	Q9BXT4
IGLEYCKEHIEDFKQ	ADNP	26	Q9H2P0
FVEYRHILDEKDCAV	APAF1	526	O14727
QLGHEEDYALGKDCI	GRK3	546	P35626
IIEELADALTYCHDK	AURKC	146	Q9UQB9
CLEHYEFLLDKAAQR	CDC5L	96	Q99459
ACKYHVAVAEAGELR	BICD2	436	Q8TD16
NVFNLDKLICGYHDE	CXCR6	171	O00574
DKLICGYHDEAISTV	CXCR6	176	O00574
KVVYECHEGFKLESS	CSMD1	2516	Q96PZ7
DVEALGLHDYCDIIK	BRD4	381	O60885
VLDELQHYCHGLESK	CDKL3	86	Q8IVW4
VAAEYGHCDVLEHLI	ASB15	216	Q8WXK1
AVKVAIDAGYRHIDC	AKR1B10	31	O60218
GLKYEEIDCLINDEH	GLCE	101	O94923
ELCALLFAKSHYDEA	APPBP2	211	Q92624
DLIGQLFYKDCHALD	ARAP2	1016	Q8WZ64
IAADKGHYKFCELLI	ANKRD17	1326	O75179
HFLAELCENDYPDVL	DIAPH1	1021	O60610
LLCDYLEKEVKFLGH	CCM2L	56	Q9NUG4
ELSGHKNIVGYLDCA	BMP2K	101	Q9NSY1
KCDANHYIILFRDAG	CAMSAP1	1506	Q5T5Y3
AVNIAYACKLLDHDE	ATP10A	896	O60312
YACKLLDHDEEVITL	ATP10A	901	O60312
HVDYALIAEETGKCF	ACAD11	446	Q709F0
LHEICDDIFAYVKDR	BAZ1A	101	Q9NRL2
AVKVAIDVGYRHIDC	AKR1B1	31	P15121
QLGHEEDYALGKDCI	GRK2	546	P25098
AAHDLALACKLDYDE	ST13	201	P50502
EGLDHALQCVDYIKA	IL13RA2	176	Q14627
ALHCDIGNAAEFYKI	RAG1	796	P15918
YKVEESAIEKHFLDC	RBM34	296	P42696
VLDTDVFLYLKHKCG	RBM43	221	Q6ZSC3
LAGDRFYDDLHCIDI	RABEPK	211	Q7Z6M1
LCKEGLPVEDAYFHS	HJV	346	Q6ZVN8
CKAEEIYKAFVHSDA	RGS1	131	Q08116
DGDHVILQKYVACLE	ITPKC	586	Q96DU7
DEYHKLKLIDFGLCA	MELK	141	Q14680
HYAAEKDEACVEVLL	ASB8	91	Q9H765
IGLDFCKYLVLDEAD	DDX3X	336	O00571
RAACFDGHLEIVKYL	FEM1C	121	Q96JP0
GFEAHVDKCLELAEY	GAD2	466	Q05329
VCEHLNLLEKDYFGL	EPB41L1	126	Q9H4G0
KEFHEYLITEGKCTL	TRIT1	286	Q9H3H1
DHALFGEVACRLYLF	GPR61	106	Q9BZJ8
VLQYDDICKIDFGTH	METAP2	241	P50579
DGKIVYCESHAFADI	LRRTM4	41	Q86VH4
AVPHKGLDCYLDSLF	MYO15A	2381	Q9UKN7
HIFYQICKGASEDER	MYO19	236	Q96H55
DYFDNGIICKLIEHN	MYO1A	431	Q9UBC5
ALGDQFYKEAIEHCR	DPF3	11	Q92784
YQKDEDSAGCHLFVV	IBTK	606	Q9P2D0
YVVFVKSDDGLEVHC	FNDC7	316	Q5VTL7
ACVVEAFAYLHSKGI	PRKG1	466	Q13976
LKQLEECIEYDFLEH	DOP1B	2281	Q9Y3R5
LCSAYGVVAAKDHDI	JMJD1C	2316	Q15652
NLAEKEYFGLEFCSH	FRMD7	36	Q6ZUT3
DKFNECGHVLYADIK	HNRNPM	671	P52272
LIYHAGESVDALCFV	KCNH5	576	Q8NCM2
IEECHYTVLGDAFKE	DDX58	826	O95786
IHLYEVIQKGCFIEE	C2CD6	206	Q53TS8
TIGCYLDIDKGHVKF	DDX1	191	Q92499
KVCEHLNLLEKDYFG	EPB41L2	246	O43491
LHYFLCDDTIEIKEL	EFHC2	251	Q5JST6
VLHGDLIDFVCKQGY	F13B	476	P05160
YCVDLASEIAKHIGI	GRIA4	446	P48058
AFVECLQKHGLEVIY	HSP90AA5P	191	Q58FG0
IVVHIYEDGIKGCDA	PDC	136	P20941
CSQLLYTGKVHEDVF	FAT2	3011	Q9NYQ8
AEKFIYDHLLCFRGE	MINDY4B	241	A8MYZ0
AVGFKLLQEEHCDIF	PDE4B	481	Q07343
KDFAAYLAFCGIVLH	PDE5A	301	O76074
AYFHEEEREGLAKIC	PDXDC1	136	Q6P996
AYFHEEEREGLAKIC	PDXDC2P	136	Q6P474
YLGLDGFVERIKHAC	PDXDC2P	346	Q6P474
EILHYVVDGIDCLLA	PRAMEF18	76	Q5VWM3
YHGLCELTAAAKEGE	MINDY1	296	Q8N5J2
YCIEHGDLELAAKFV	IMMT	696	Q16891
EFGLVEEKVLCRIHY	LHX6	171	Q9UPM6
LLVFEFCDLGDLKAY	LMTK2	211	Q8IWU2
DHKDYIFLLLIGFCI	LRRC52	241	Q8N7C0
QLKDKADFCIIHYAG	MYH9	561	P35579
YGDEELHLCVSRKHF	INSR	891	P06213
GLECTFIDDISAYHK	PADI2	626	Q9Y2J8
IDYTHIEVLIDGKGC	MFSD6	346	Q6ZSS7
GLCLHKDYVAGREFV	PLA2G4F	641	Q68DD2
CHSRVFIEGHYELKE	IQCF5	106	A8MTL0
FEGLSEDLHEYLVAC	PLCXD1	156	Q9NUJ7
EDLHEYLVACIKNIF	PLCXD1	161	Q9NUJ7
YFHVTCAQKEGLLSE	PHF14	466	O94880
GHCLKEIYLVDVSEK	PARP14	951	Q460N5
ESFVACEHLFLKLVG	ITPRIPL1	396	Q6GPH6
EALAKHEAFFIRCGI	PCID2	296	Q5JVF3
LGLIDIIFQYIHCDE	WDPCP	486	O95876
EGRVYKCLFNHKFEE	GLG1	331	Q92896
AQEHSILCYKILGDF	FHIP1A	1021	Q05DH4
QLIAAYKDFCEHGTK	HECTD1	1946	Q9ULT8
KCHIEDLDFAEYILG	FBH1	856	Q8NFZ0
KEFAYEQEVALHCAL	IL1RL1	456	Q01638
DTAKYILANIGDHFC	KDM3A	616	Q9Y4C1
LENCLGHVEDDYILF	GPN3	91	Q9UHW5
LAGDEEEHAVLLCNY	CC2D2A	1361	Q9P2K1
ADLIGLLEYKEGHCE	DACT1	211	Q9NYF0
SDEYCKHHFLVGLLL	DOCK11	1106	Q5JSL3
IAKDITDHRAFGYVC	DAB1	116	O75553
QIICKYLLSEEEDHF	GNPAT	581	O15228
VNDDGCILHTDLYKF	EFCAB7	116	A8K855
VCDYELARLDAEKAH	FUT11	391	Q495W5
LKDIHFGQCYKISDE	FBXL17	466	Q9UF56
IELFDILDHYTKNCD	UGT8	101	Q16880
CLDKYFQHLCDDLEV	CENPT	486	Q96BT3
AICLKYAGVHAENAE	C1GALT1C1L	221	P0DN25
KVVCHFSGKAYADEE	CRIM1	816	Q9NZV1
LEEREVLLYCDFHGH	AGBL2	546	Q5U5Z8
FTIEDLKSLGYHVCD	AGBL2	646	Q5U5Z8
GCKSVHYDLVFLLDT	COL22A1	31	Q8NFW1
DYEQKERFLLFCVHG	MARK1	731	Q9P0L2
LLECLEFDPEEFYHL	MAST2	426	Q6P0Q8
NGYAFCIRHVLEDKT	INO80D	31	Q53TQ3
EDESLKGCELYVQLH	PRKAR1B	11	P31321
INEHDYAKAAFCLEE	EMC2	166	Q15006
KHAALGFFDCLRAEV	DHRS7C	196	A6NNS2
LCYEFIQGEALDPKH	ETNK1	206	Q9HBU6
VLGSDVEFHCKVYSD	FGFR3	266	P22607
EGYCVELAAEIAKHV	GRIA1	436	P42261
RFEGYCIDLLKELAH	GRIK3	461	Q13003
KGSIYLVFDFCEHDL	CDK9	96	P50750
HALCKYLDELGFTVF	HSD17B2	96	P37059
ACDKKGIHYLATVFE	S100A7A	46	Q86SG5
LHITPEKFYVEACDD	SACM1L	11	Q9NTJ5
VLDLYLGTHFKLDNC	SACS	2681	Q9NZJ4
YLFDVCSHQDKEKGL	SLC45A2	166	Q9UMX9
VLSIVKALDYESCEH	CDH15	321	P55291
TLFKLLGYDVHVLCD	CASP2	231	P42575
INYCKLVGVEEHLRD	CFAP74	546	Q9C0B2
ELHVIDVKFLYGCQA	DDB1	161	Q16531
DKADFCIIHYAGKVD	MYH10	571	P35580
ILGSFQEDIYCHKFI	TACR2	271	P21452
CEEQLSKQVHYDFGL	DNAH5	2141	Q8TE73
DSELYQVLHACKDIG	DPYSL5	171	Q9BPU6
ADFLREYVTLHKGCF	LIPE	451	Q05469
KDCLGDFIEHYAHLG	PURG	116	Q9UJV8
EEDKGVLNDFHKCIY	JARID2	801	Q92833
GKILHIDFGDCFEVA	MTOR	2351	P42345
IYAGHLADVDCVKFH	TAF5L	421	O75529
EILTFKEHSDYVRCG	UTP15	156	Q8TED0
IDLNEHKDYFVCGVK	UVRAG	331	Q9P2Y5
LFDEKCGYNNEHLLL	TRIM36	516	Q9NQ86
GCEVTILFADLHAYL	YARS1	66	P54577
YCDHENAAFKDVALV	TOR1AIP2	381	Q8NFQ8
SDYQDLCSIGKEHVF	SYNE1	3901	Q8NF91
IKEHEACFSEEGCLY	SYNE2	976	Q8WXH0
AIARLIEFYKHESCG	NDUFV1	366	P49821
EILHYVVDGIDCLLA	PRAMEF19	76	Q5SWL8
TQLEDEALKYIGAHC	FBXL20	206	Q96IG2
QHYKGSDFDCELRLL	HNRNPK	136	P61978
GRFEKASVEYQEHLC	SMG1	1116	Q96Q15
GCAYKAIIEHEILHA	MEP1A	146	Q16819
YFLKQGEDHCLEGES	PSD4	816	Q8NDX1
ILEVHKDFLAALEYC	PREX1	106	Q8TCU6
CTFADKIHLAYERGA	RNF128	126	Q8TEB7
LADCLGHYGYIDLEL	POLR3A	76	O14802
KYDGIDCVYGLELHR	SPIN2A	86	Q99865
ETVEFCTGDYAKEHL	PHYHIP	106	Q92561
VDNEAVYDICHRKLG	TUBAL3	211	A6NHL2
YQHFLQDCVDGLFKE	DLC1	1321	Q96QB1
AIEYDCKEEHAEFVL	SATB1	86	Q01826
EEGEKLATELACAFY	RERG	131	Q96A58
EAFYKIFHLQAACEI	ADD2	301	P35612
LTIAADKGHYKFCEL	ANKHD1	1296	Q8IWZ3
VFKFIGDYDEVHLHC	TECTA	2026	O75443
LLHYSIDEAECFEKA	TBC1D24	141	Q9ULP9
FDGDCYIILAIHKTA	VIL1	41	P09327
SHEDCYILDQGGLKI	VIL1	281	P09327
VGIEDCLHIEFEYNK	VPS26B	166	Q4G0F5
YAEAKAVCEFEGGHL	TNFAIP6	51	P98066
TLCEKDHIAFEAAYQ	ZSWIM5	971	Q9P217
ELYGEHAKAVAALPC	ZNF865	46	P0CJ78
LIEFYHLVGDCELSV	VPS13A	891	Q96RL7
ALIYSFCENHDKAIE	TTC6	31	Q86TZ1
GCGYLAHVLAEEAEI	PDGFA	11	P04085
EIYCRLFDHVKTGIE	SLC9A2	501	Q9UBY0
KYDGIDCVYGLELHR	SPIN2B	86	Q9BPZ2
CAKLYVDIGFVNLDH	SLCO1C1	246	Q9NYB5
HLFICVAIVAIYGDD	TBC1D16	641	Q8TBP0
TVLERDGHYAVAAKC	GEMIN5	1031	Q8TEQ6
LHLDDGLINCAKYFI	PIEZO2	1101	Q9H5I5
CGRYIEDHALKHFEE	USP49	46	Q70CQ1
NGGLYCALEDHKILE	UAP1L1	226	Q3KQV9
AGDFFIFCLKELTHV	TANGO6	591	Q9C0B7
YHIGDFCFQEIEKEI	ZNF808	96	Q8N4W9
LSDGKVFIHLCNYIE	TIMP4	121	Q99727
YVLKSCAEFIETHGI	ARHGAP31	36	Q2M1Z3
GICEYHEKNYAAALE	SUGT1	86	Q9Y2Z0
ACSYGHYEVAELLVK	TNKS2	566	Q9H2K2
VLEYCGEVLDHKEFK	SETD2	1576	Q9BYW2
DDIYFQAHKAVLAAC	ZBTB1	31	Q9Y2K1
EAHDAEVLCLEYSKP	WDR62	531	O43379
VLFDHVGCLKKYDTV	TOP2A	1001	P11388
LLDAVGQCEEYVLKH	YAE1	106	Q9NRH1
EDECFYAHSLVELKV	ZC3H7A	646	Q8IWR0
YFHIGETEKRCFIEE	TMED4	31	Q7Z7H5
EAAKELYTHLCDVVD	ZZEF1	826	O43149
LYTHLCDVVDKVDGD	ZZEF1	831	O43149
SCDLEFDEYQKIHTG	ZNF529	181	Q6P280
CAALEEFIHEGYLIG	VPS9D1	591	Q9Y2B5
VCGDIHGQFYDLKEL	PPP4C	51	P60510
EHKVFYTELLNLCEA	TRRAP	1331	Q9Y4A5
VHRYEGVDKNKFCDL	ZMAT1	111	Q5H9K5
KHEEDLLGYYVDCCV	MYOM2	636	P54296
LDCFYLKLHGVKLEA	MYRF	426	Q9Y2G1
ETEKLCDYFSEHLGV	NECAB3	91	Q96P71